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Autophagy is highly conserved cellular process that function in ensuring the turnover of 
proteins and organelles in a number of different cell types. Mitophagy is a selective form of 
autophagy which serves to target and rid the cell of damaged or superfluous mitochondria. The 
process is central to preventing the accumulation of defective mitochondria and is particularly 
important in neurons, which rely exclusively on mitochondria to sustain their immense 
metabolic needs. Dysregulation of autophagy is believed to contribute to the 
neurodegeneration seen in such disorders as Parkinson’s disease and cerebral ischemia. 
However, further understanding of the role of neuronal autophagy under stress conditions, and 
the relevant players involved in this process is required. In recent years, two homologous 
proteins expressed only in higher eukaryotes have been described to play roles in mammalian 
autophagy and mitophagy. Tumour- protein 53-induced nuclear protein 2 (Tp53INP2) has a 
bi-functional role as a modulator of autophagy and gene transcription. This protein was shown 
to participate in non-neuronal autophagy, however its role in mitophagy is not well understood. 
Additionally, tumour- protein 53-induced nuclear protein 1 (Tp53INP1), has been suggested 
to play a role in autophagy as well as PINK1/Parkin mitophagy, however neither protein has 
been investigated in neuronal paradigms. Our findings demonstrate that cerebellar granule 
neurons and primary cortical neurons from Tp53INP1-/- mice demonstrate attenuated 
autophagy induction in response to trophic factor deprivation and hypoxic stress, respectively. 
We also demonstrate through confocal microscopy that Tp53INP2 responds to CCCP-induced 
mitochondrial stress by shuttling out of the nucleus and co-localizing with autophagosomal 
protein LC3, suggesting that it may play a role in mitophagy.  
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Chapter 1  
1 Introduction 
1.1 Autophagy 
Autophagy is an intracellular response involving the sequestration and subsequent 
degradation of old, damaged or superfluous macromolecules and organelles at the 
lysosome. This catabolic process is most notably induced under starvation conditions 
characterized by a deficiency in glucose or amino acids and an increase in AMP-activated 
protein kinase (AMPK). In addition to this, autophagy functions to clear the cell of 
damaged proteins and organelles and has conserved roles in cell differentiation and 
development (Mizushima & Levine , 2010).  
 
The process can take place through three major forms including chaperone-mediated 
autophagy (CMA) in which soluble unfolded proteins with the KFERQ motif are 
recognized and transported to the lysosome by heat shock cognate  protein 70kDa (hsc70), 
microautophagy in which small cytosolic volumes are directly engulfed through 
invagination of the lysosomal membrane, as well as macroautophagy involving expansion 
of an isolation membrane around the contents of interest into a double membraned vesicle, 
and its subsequent degradation via fusion with the lysosome (Figure 1.1) (Nedelsky, Todd 
& Taylor, 2008). Among these, macroautophagy (hereafter referred to as autophagy) has 
been the most extensively studied. Under basal conditions the process serves to 
continuously recycle intracellular pools of macromolecules and organelles, playing a 
critical role in maintaining cellular homeostasis. Following internal or external stressors, 
the process is upregulated thereby exerting key cytoprotective roles. Autophagy was 
initially believed to work non-selectively in response to starvation, resulting in bulk 
degradation of cytosolic contents. However, studies have demonstrated the ability of the 
process to selectively target specific molecules dependent on the stress induced, although 
how this selectivity is initiated is still not well understood. Examples of selective autophagy 
that have been observed include mitochondria (mitophagy), ribosomes (ribophagy), 
peroxisomes (pexophagy), aggregate proteins (aggrephagy) and foreign invaders 
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(xenophagy) (Stolz, Ernst & Dikic, 2014).  This selectivity is largely carried out by 
autophagy receptors which are able to recognize and bridge cargo as well as 
autophagosomal membrane protein microtubule-associated protein light chain 3 (LC3). 
Since one of the most prevalent and recognized autophagy signals involves ubiquitin 
modifications, most of these receptors also retain a ubiquitin binding domain, in addition 
to their LC3-interacting region (LIR). An example of these includes p62/SQSTM1 
(sequestosome-1) and neighbor of BRCA1 gene 1 protein (NBR1) (Stolz, Ernst & Dikic, 
2014). 
1.2 Molecular Mechanisms of Autophagy 
Autophagy induction is regulated primarily by mammalian target of rapamycin (mTOR) 
kinase which acts to prevent autophagy from initiating during nutrient abundant conditions 
by blocking Unc-51-like kinase (ULK)1/2 complex, an initial inducer of autophagy. 
However, during starvation conditions, mTOR is inhibited by 5’ adenosine 
monophosphate-activated protein kinase (AMPK), as well as tuberous sclerosis complex 1 
and 2 (TSC1-TSC2), thereby causing the activation of ULK1/2 complex. Autophagosome 
biogenesis begins with the proteins of the ULK1/2 complex assembling. Nucleation of the 
autophagosome requires the activated ULK1/2 complex to autophosphorylate and 
phosphorylate autophagy related protein 13 (ATG13) and FAK family-interacting protein 
of 200 kDa (FIP200), two proteins in the ULK1/2 complex (Figure 1.2). The activated 
complex then phosphorylates Beclin1 thereby activating the Beclin1-vacuolar protein 
sorting 34 (VSP34) complex which acts as a class III phosphoinositide 3-kinase (PI3K). 
The complex produces phosphatidylinositol 3-phosphate (PI3P) which recruits WD-repeat 
protein interacting with phosphoinositides (WIPI) and EEA1 domain-containing protein 1 
(DFCP1) which play roles in generating the isolation membrane (phagophore) that serves 
as the premature membrane of the autophagosome (Kiriyama & Nochi, 2015).  
 
Next, a complex composed of ATG12, ATG5 and ATG16 is recruited to the 
autophagosomal membrane to facilitate the lipidation of LC3, a protein necessary for the 
expansion of the isolation membrane with a phosphatidylethanolamine (PE) lipid tail. LC3, 
is associated directly with the autophagsome and remains associated until the process is 
complete. Unprocessed pro-LC3 is co-translationally cleaved into its cytosolic form LC3-
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I. Upon autophagy stimulus, LC3-I becomes conjugated to a PE lipid tail to form LC3-II, 
which can now covalently bind directly to the autophagosomal membrane and contribute 
to the elongation of the isolation membrane into the autophagosome (Tanida, Ueno, & 
Kominami, 2004). This direct association between LC3-II and the autophagosome allows 
it to serve as a reliable marker of autophagsomes for immunofluorescence and 
immunoblotting studies (Figure 1.3). Additionally, the generation and turnover of LC3-II 
is used as an accurate indication of autophagy flux, as the increase in conversion of LC3-I 
to LC3-II indicates an increase in autophagosome formation and therefore an increase in 
autophagy (Nedelsky, Todd, & Taylor , 2008).  Since autophagy is a dynamic process, the 
use of lysosomal inhibitors such as chloroquine (CQ) and bafilomycin A1 (baf A1) can 
further capture the change in autophagic flux by preventing autophagosome turnover and 
thereby LC3-II turnover.  
 
Upon enclosure of the double membraned autophagosome around the cargo, the 
autophagosome fuses with the lysosome to form the autolysosome. This fusion allows for 
lysosomal acid hydrolases to degrade the inner autophagosomal membrane as well as the 
cargo within. The degradation products are then released back to the cytosol to be recycled 






Figure 1.1 The Mechanism of Mammalian Autophagy: In mammalian autophagy, 
initiation begins with the expansion of the isolation membrane by several autophagy-
related proteins including LC3 around the cellular contents to be removed. The 
autophagosome is formed upon closure of the double-membraned organelle. Fusion of the 
lysosome with the autophagosome results in a hybrid autolysosome, in which lysosomal 
acid hydrolases degrade autophagosomal contents and inner autophagosomal membrane. 








Figure 1.1.  
Figure 1.2  The signaling pathway of mammalian autophagy: Autophagy is primarily regulated 
by activated mTOR, a nutrient sensing kinase that serves to prevent autophagy induction during 
nutrient abundant conditions. However, as AMP concentrations rise, 5’ adenosine monophosphate-
activated protein kinase (AMPK) inactivates mTOR to promote autophagy by allowing the 
autophosphorylation and activation of Unc-51-like kinase 1/2 (ULK1/2), therefore allowing it to 
activate the Beclin1-VPS34 complex. This complex functions as a class III phosphoinositide 3-
kinase (PI3K) producing phosphatidylinositol 3-phosphate (PI3P) which serves to recruit WIPI 
and DFCP1. WIPI and DFCP1 are PI3P binding proteins that aid in formation of the phagophore 
membrane. ULK1/2 also interacts with ATG16- ATG5-ATG12, a complex that functions to 
conjugate phosphatidylethanolamine (PE) to LC3-I to form the activated LC3-II that contributes 
to the formation and elongation of the autophagosomal membrane. Additionally, mTOR 
inactivation can negatively regulated by tuberous sclerosis complex 1 and 2 (TSC1-TSC2) 
complex, by stimulating the conversion of Ras homolog enriched in brain (Rheb)-GTP to Rheb-
GDP. Under anabolic conditions TSC1-TSC2 complex is inhibited by the phosphoinositide 3-






Figure 1.3. Processing of LC3 upon autophagy induction. Unprocessed Microtubule-
associated protein 1 light chain 3 (Pro-LC3) is synthesized is cleaved of is amino acids 
from the C-terminus side to produce LC3-I.  LC3-I becomes conjugated to 
phosphatidylethanolamine tail upon autophagy induction converting it to LC3-II. LC3-II 
is incorporated into the autophagosomal membrane to contribute the elongation of the 
autophagosome. LC3-II is the only marker that is reliably associated with completed 
autophagosomes. Upon autophagy completion, LC3-II bound to the inner autophagosomal 
membrane becomes degraded, and that on the outer autophagosomal membrane is cleaved 
















1.3 Neuronal Autophagy  
The demand for basal autophagy can often vary depending on the tissue, being particularly 
important in the liver and in cells that do not divide after differentiation such as myocytes 
and neurons. It was generally believed that basal autophagy in neurons occurred at low 
levels due to the neuronal ability to not only use glucose, but ketones as an alternative 
source of energy. Additionally, neighboring astrocytes can provide short term energy stores 
through the conversion of glucose into lactate (Gabryel, Kost and Kasprowska, 2012). 
Basal autophagy is thought to be a protective process in neurons, playing important roles 
in synaptic plasticity, anti-inflammatory roles of glial cells and myelination of 
oligodendrocytes (Nah, Yuan, & Jong, 2015). The process is constitutive in neurons, acting 
non-selectively under nutrient deprived conditions. It plays a crucial role in the homeostasis 
of neurons, and the removal of aggregate prone proteins specifically, as neurons cannot 
dilute their cellular burdens through cell division. In particular, because neurons retain 
highly specialized structures that rely heavily on adequate intracellular communication and 
transport of material across large axonal distances, well-regulated quality control 
mechanisms such as autophagy must exist.   
 
Additionally, previous studies have used knockout models to demonstrate the importance 
of autophagy in various cell types including neurons. Unlike conventional atg5 and beclin1 
knockout mice which do not survive past embryogenesis, neural-tissue-specific knockouts 
which survive past the postnatal starvation period, display progressive motor deficits. 
Specifically, Komatsu et al., demonstrated that complete impairment of autophagy in the 
central nervous system resulted in marked reductions in large pyramidal cells and Purkinje 
cells in the cortical and cerebral cortices, respectively (Komatsu, et al., 2006). Additionally 
an age dependent increase in the number and size of ubiquitin positive inclusion bodies, 
known pathological hallmarks of various neurodegenerative diseases (NDs) were also 
observed (Komatsu et al., 2006). Therefore, it is evident that basal levels of autophagy are 
imperative to the functioning and survival of neurons and that impairment of these 
processes can lead to the accumulation of aberrant proteins.  
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1.4 Autophagy and Neurodegeneration  
Many types of neurodegenerative diseases are accompanied by the accumulation of 
aggregate ubiquitinated proteins as well as an accumulation of autophagosomes. The 
former indicative of inadequate proteosomal or lysosomal degradation processes, and the 
latter indicating an imbalance between autophagosome formation and autophagosome 
degradation. In particular, this fundamental balance between too little or too much 
autophagy is believed to contribute to its dual role as being cytoprotective and a contributor 
of cell death (Figure 1.4).   
 
Figure 1.4 The balance in autophagic flux in neurons is crucial to cellular 
homeostasis: The abnormal accumulation of autophagic vacuoles is common neuronal 
phenotype in neurodegenerative brains. A. The balance between autophagosome formation 
at basal levels or as a result of stress induction is balanced with autophagosome degradation 
at the lysosome, thereby maintain homeostasis. B. Under neurodegenerative states, either 
increased autophagosome formation or impaired degradation can lead to an increase in 
autophagic vacuoles deposition, and thereby autophagic stress. 
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1.4.1 Alzheimer’s Disease  
Alzheimer’s disease (AD) is the most common form of senile dementia and has been 
characterized by the accumulation of amyloid beta (Aβ) plaques. Electron studies on AD 
brains provide evidence of alteration of autophagy in dystrophic neurons. These neurites 
retained abundant accumulation of autophagic vacuoles (AV), particular immature AVs 
suggesting impairment of late stage autophagy as well as retrograde transport to the 
lysosomes (Son, Shim, Kim, Ha & Han, 2012). Additionally, immunolabelling studies 
identified AVs to contain large amounts of Aβ, serving as a reservoir for both full length 
amyloid precursor protein (APP) and β-secretase cleaved APP. Furthermore, 
downregulation of beclin1 has been observed in AD brains. The reduced expression of 
beclin1 in APP transgenic mice resulted in increased intraneuronal Aβ accumulation and 
extracellular Aβ deposition, as well as increased neurodegeneration (Nah, Yuan, & Jong, 
2015).  
1.4.2 Huntington’s Disease 
Huntington’s disease (HD) is a movement disorder characterized by the loss of motor 
control and emergence of cognitive deficits. It is caused by expanded trinucleotide repeats 
(CAG) in the huntingtin (htt) gene that results in an abnormally long poly-glutamine 
(polyQ) expansion at the N-terminus of the protein. The polyQ expansion affects the 
structure of the protein and therefore its function, in addition to creating toxic aggregates 
that damage subcortical regions of the forebrain and the striatum. Htt plays an important 
role in autophagy by contributing to cargo recognition through its interaction with 
autophagosomal membrane-bound LC3 and p62-bound cargo (Rui, et al., 2015). However, 
alterations in autophagy have been observed in various models of HD, contributing to the 
insufficient clearance of mutant htt aggregates. Several reports have suggested that both 
mTOR-dependent and independent pathways enhance htt clearance and alleviate HD-
associated behavioural and motor phenotypes (Rui et al., 2015).  
1.4.3 Parkinson’s Disease  
Parkinson’s disease (PD) is a progressive movement disorder that results in the loss of 
dopaminergic neurons in the substantia nigra. The disease is associated with the 
accumulation of cytosolic protein α-synuclein within inclusions called Lewy bodies, and 
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has displayed patterns of increased autophagosome-like structures.  90% of PD cases are 
sporadic, however familial mutations occur in specific genes including, α -synuclein 
(SNCA), Parkin (PARK2), PTEN-induced putative kinase 1 (PINK1) (PARK6), DJ-
1(PARK7), B-glucocerebrosidase (GBA), and leucine-rich repeat kinase 2 (LRRK2). 
Accounting for the majority of autosomal recessive cases involve mutations in Parkin and 
PINK1, two proteins involved in mitophagy, the targeted removal of mitochondria by the 
autophagosome. Thus, these mutations abolish the cells ability to clear mitochondria, 
resulting in the accumulation of damaged mitochondria and the release of reactive oxygen 
species (ROS) as well as the potential initiation of apoptotic events (Nixon & Yang, 2012). 
Additionally, α -synuclein contains a KFERQ motif, and can thereby be degraded by both 
macroautophagy as well as CMA. However, mutations in the protein cause it to bind 
abnormally tightly to lysosomal associated membrane protein 2 (LAMP2) preventing its 
own uptake into the lysosome as well as uptake of other CMA substrates (Kiriyama & 
Nochi, 2015). 
1.5 Mitophagy  
Mitochondria are organelles central to cellular function and homeostasis. They provide an 
essential source of ATP necessary for cell survival as well as contribute to cellular stress 
responses such as autophagy and apoptosis. These complex organelles routinely undergo 
processes of fission and fusion that serve to modulate their form and function. 
Mitochondria are abundant in most cells and can occupy 10-40% of the cell volume 
(Hamacher-Brady & Brady, 2016). They can exist as a homogenous population or 
heterogeneously as seen in neuronal cell types. Appropriate mitochondrial functioning and 
quality control is particularly important in neurons. The central nervous system (CNS) 
while accounting for only 2% of the body’s weight, consumes up to 20% of inspired oxygen 
at rest. This is due to the nervous system’s vital dependence on oxidative phosphorylation 
to produce to immense amounts of ATP necessary for the highly specialized functions of 
neurons (Kann & Kovacs, 2006). In addition to ATP production, mitochondria function in 
establishing ion gradients for neurotransmission. Additionally, the unique morphology of 
neurons require mitochondrial trafficking through narrow axons to distant terminals, 
creating vulnerability to trafficking defects. This can be exasperated by their post-mitotic 
nature, debilitating them from preventing the build-up of damaged cell contents through 
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cellular division. Accumulation of damaged mitochondria via dysregulated mitophagy can 
result in increased release of ROS as well as the premature release of pro-apoptotic signals 
through mitochondrial outer membrane permeabilization (MOMP).  
 
Mitophagy is a form of selective autophagy pathway that utilizes the cell’s autophagic 
machinery to specifically remove mitochondria. The process occurs under physiological 
conditions, during the maturation of erythrocytes and the development of a fertilized 
oocyte, and as a form of quality control to maintain the balance between mitochondrial 
biogenesis and turnover (Kann & Kovacs, 2006).  Mitophagy can also be induced in 
response to mitochondrial damaging conditions such as hypoxia, resulting in the removal 
of dysfunctional mitochondria. The process requires specific mitochondrial proteins to 
mark the mitochondria for recognition by the phagophore, followed by its subsequent 
degradation at the lysosome. In healthy mitochondria, oxidative phosphorylation is a key 
functional unit that generates ROS as a by-product. In dysfunctional mitochondria 
however, ROS levels become elevated and activate apoptosis (Jezek, Cooper, & Strich, 
2018). When mitochondria become deficient, they undergo fission, becoming separated 
from the mitochondrial network. These mitochondria can then be separated into polarized 
and depolarized mitochondria, in which the latter is targeted for mitophagy. The process 
of fission is mediated by dynamin-related protein 1 (Drp1), a cytosolic protein that wraps 
around the mitochondria, severing the inner and outer membrane between two daughter 
cells forcing division that results in unequal polarization (Ashrafi and Schwarz, 2012).  
1.5.1 PINK1/Parkin Mitophagy  
One of the most studied pathways of mitophagy is known as PINK1/ Parkin mitophagy. 
PINK1 is a serine-threonine protein kinase that acts as a mitochondrial stress sensor, 
initiating mitophagy during mitochondrial membrane depolarization, misfolded 
mitochondrial protein and ROS generation (Song, Mihara, Chen, Scorrano & Dorn, 2015). 
Under basal conditions when mitochondria are healthy, PINK1 is targeted to the 
mitochondria and its accumulation on the outer mitochondrial membrane is prevented by 
its import through the outer mitochondrial membrane. Transport is facilitated by both outer 
mitochondrial membrane translocase (TOM) complex and inner mitochondrial membrane 
translocase (TIM) complex, where it is cleaved by mitochondrial proteases presenilin-
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associated rhomboid-like protein (PARL) and mitochondrial processing peptidase (MPP). 
The cleaved kinase is then released into the cytosol, and degraded by the ubiquitin-
proteasome system (UPS) (Martinez-Vincente, 2017). For this reason, mitochondrial levels 
of PINK1 are low in healthy mitochondria. Upon mitochondrial damage however, 
mitochondria lose their membrane potential preventing the complete processing of PINK1. 
Full-length PINK1 rapidly accumulate across the surface of the mitochondria with its 
kinase domain facing the cytosol. This allows it to phosphorylate ubiquitin substrates on 
the outer mitochondrial membrane including mitofuscin 2 (Mfn2), a protein responsible 
for mitochondrial fusion (Filadi, Pendin and Pizzo, 2018). Phosphorylation of Mfn2 signals 
Parkin translocation to the mitochondria which allows PINK1 to phosphorylate Parkin at 
serine65, thereby activating it. Parkin is an E3 ubiquitin ligase that is predominantly located 
in the cytosol, however once recruited to the mitochondria, Mfn2 serves as a receptor for 
Parkin bringing it in close proximity with the mitochondrial substrates, of which it then 
poly-ubiquitinates (Song, Mihara, Chen, Scorrano & Dorn, 2015). Poly-ubiquitination of 
the mitochondrial outer membrane proteins is recognized by sequestosom-1 
(p62/SQSTM1), a protein that binds both LC3 of the autophagosome through its LC3-
interacting region and ubiquitin residues via its ubiquitin associated domain. Recruitment 
of the autophagosome to the damaged mitochondria then initiates autophagic removal 
(Figure 1.5). Additionally, it was demonstrated that Parkin was not necessary for 
mitophagy induction, but rather enhanced the process. 
 
This process of mitophagy is particularly imperative to neuronal health due to their post-
mitotic nature. This in combination with their heavy dependence on oxidative 
phosphorylation for energy production, places a heightened susceptibility to mitochondrial 
dysfunction. Dysfunctional mitophagy is closely linked to autosomal-recessive forms of 
Parkinson’s disease, forms of cancer and heart disease (Redmann, Dodson, Boyer-Guittaut, 








Figure 1.5 PINK1/Parkin Mitophagy Pathway: Under functional mitophagy program, 
PINK1 accumulates on the surface of depolarized mitochondria, as its import into the inner 
mitochondrial membrane is prevented. Upon accumulation, it recruits the E3 ubiquitin 
ligase Parkin, which acts to ubiquitinate various outer mitochondrial proteins. 
Polyubiquitination of the mitochondria targets the mitochondria for removal by the 
autophagosome, via interaction between autophagosomal-bound LC3 and ubiquitin-bound 
p62. Under dysregulated mitophagy, depolarized mitochondria are not targeted for removal 
and accumulate leading to the release of reactive oxygen species (ROS) and pro-apoptotic 









1.6 Cerebral Ischemia  
Defects in autophagy and mitophagy have been implicated in aging, diabetes and multiple 
NDs. Recently however evidence of autophagic induction during ischemic/hypoxic 
conditions has provoked the question of whether autophagy plays important roles during 
cerebral ischemia. 
 
Cerebral ischemia is a form of stroke which is caused by insufficient blood flow to the 
brain resulting in reduced oxygen and glucose supply to neuronal tissue. There exist two 
main forms, global ischemia resulting from blocked blood flow to the entire brain and focal 
ischemia caused by occlusion of certain cerebral blood vessels (Tang, Tian , Yi , & Chen , 
2016). Stroke is the third leading cause of death worldwide and the major cause of adult 
disability (Liu et al., 2014). When blood flow to the brain is blocked, cells undergo 
molecular changes including excitotoxicity, oxidative stress, mitochondrial dysfunction 
and inflammation all of which can lead to irreversible tissue damage and cell death. 
Researchers have identified three major pathways of ischemic cell death including necrotic, 
apoptotic and autophagocytotic cell death. Unlike necrosis and apoptosis which definitely 
lead to tissue injury, autophagy could potentially serve as a therapeutic target for ischemic 
brain injury. In 2017, Guo demonstrated that upregulation of hypoxia-inducible factor-1a 
(HIF-1a) a key transcription factor that regulates gene expression during hypoxic stress in 
a human cortical neuron cell line resulted in increased autophagy as well as reduced cell 
apoptosis (Guo, 2017). However, it is still controversial whether induction of 
autophagy/mitophagy during ischemia is neuroprotective or neurodegenerative. 
Additionally, the complexity of the autophagic pathway invites further investigation into 
the molecular players involved.  
1.7 Tumour-protein-53-induced nuclear proteins 1 & 2  
In recent years, two homologous proteins expressed only in higher eukaryotes have been 
described to play roles in mammalian autophagy and mitophagy. Tumour- protein 53-
induced nuclear protein (Tp53INP1) also known as stress inducible protein (SIP) is a target 
gene of p53 that functions mainly to induce the expression of genes involved in cell cycle 
arrest and apoptosis and tumour-protein 53-induced nuclear protein 2 (Tp53INP2) also 
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known as diabetes and obesity regulated (DOR) gene, which has a bifunctional role as a 
modulator of autophagy and gene transcription.   Both genes are highly conserved in 
mammals and are believed to have arisen through a gene duplication event from the 
ancestral TP53INP gene, found in Drosophila. Both proteins are ubiquitously expressed, 
with Tp53INP1 having greater expression in the lymphoid organs, and Tp53INP2 in highly 
metabolic tissue such as muscle and the CNS (Saadi, Seillier & Carrier, 2015). Key to their 
participation in autophagy are two highly conserved domains important nucleocytoplasmic 
shuttling (nuclear export signal (NES)) upon autophagy induction and permitting 
interaction with autophagy family proteins (LC3-interacting region (LIR)) (Sancho et al., 
2012). 
 
The Tp53INP1 gene encodes two different isoforms, Tp53INP1α and Tp53INP1β, which 
are identical except for an additional C-terminal region on Tp53INP1β. Regardless of the 
minor structural difference, there are no functional difference between the two isoforms to 
date. Tp53INP1α/β are both gene targets of p53, as well as transcriptional activators of 
p53. Their ability to influence p53 expression occurs through their interaction with kinases 
homeodomain-interaction protein kinase 2 (HIPK2) and protein kinase C delta (PKCδ), 
which in turn act to phosphorylate p53 creating a positive feedback loop (Seillier et al., 
2012). Tp53INP1 is localized in sub-nuclear structures called promyelocytic leukaemia 
protein nuclear bodies (PML-NBs), of which is also believed to be the site that HIPK2 
binds and phosphorylates p53. Through various gain of function and loss of function 
studies, Tp53INP1 was shown to be involved in cell cycle regulation, apoptosis, cell 
migration and adhesion and ROS regulation. Additionally, it plays a key role in cellular 
homeostasis by affecting autophagy by its binding to LC3. Studies have demonstrated that 
ectopic expression of Tp53INP1 promotes autophagy-dependent cell death. Interestingly, 
in 2015 a study demonstrated that immortalized mouse embryonic fibroblasts with knocked 
down Tp53INP1 expression had increased mitochondrial mass consistent with decreased 
levels of PINK1 and Parkin (Seillier et al., 2015). Additionally, because defective 
mitochondria produce increased ROS, this demonstrated that Tp53INP1 involvement in 




The paralog of Tp53INP1, Tp53INP2 has also been demonstrated to play an important role 
in autophagy through its interaction with autophagosomal proteins. In 2012, it was 
demonstrated that Tp53INP2 binds to LC3 and LC3-related proteins GABARAP and 
GABARAP-like2 in an autophagy-dependent manner, and that the absence of Tp53INP2 
leads to less effective mTOR-dependent autophagy induction as indicated by a markedly 
reduced number of autophagosomes (Nowak et al., 2009). Ectopic expression of Tp53INP2 
however does not significantly affect cell cycle arrest nor apoptosis, and therefore does not 
share the same functions as Tp53INP1. It does however share a functional role in 
transcription by serving as a coactivator of thyroid hormone receptor.  Although Tp53INP1 
does appear to affect autophagy similarly to Tp53INP2, the regulation of these proteins are 
different. For example, stressors will induce Tp53INP1 gene expression, however only 
cause Tp53INP2 translocation from the nucleus (Nowak, et al., 2012). Additionally, 
whether Tp53INP2 plays a role in mitophagy and ROS regulation is still not known. 
However there is evidence suggesting that both proteins may serves as dual regulators of 
autophagy, which could provide two potentially powerful gene targets (Sancho et al., 
2012). 
1.8 Objective of this Thesis 
Neuronal autophagy plays a critical role in the homeostasis of neurons, and the 
maintenance of protein and organelle quality control. The post-mitotic nature of neurons 
necessitates an adequate balance between autophagosome formation and degradation. Any 
impairment in this balance or to the function of autophagy can be detrimental to neurons 
and contribute to neurodegeneration as seen in such disorders as Parkinson’s disease and 
cerebral ischemia. Therefore, an understanding of the key regulators of neuronal 
autophagy, particularly during stress induction, is vital to understanding the mechanisms 
that underlie the of role autophagy in neurons, as well as shed light on what contributes to 
is dysregulation in the diseased neurodegenerative states. Tp53INP1 and Tp53INP2 are 
two homologous proteins of which have been demonstrated to play important roles in non-
neuronal autophagy. There function in autophagy is mainly attributed to a highly conserved 
LIR domain which allows the proteins to bind directly to the autophagosomal membrane 
and the NES region which allows nucleocytoplasmic shuttling upon autophagy induction. 
Tp53INP1 has also been shown to participate in PINK1/Parkin mitophagy, however to date 
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there is no evidence of Tp53INP2’s role during mitochondrial stress. The heavy reliance 
of neurons on autophagic and mitophagic processes, as well as evidence of the 
dysregulation of these processes in disease phenotypes, warrants the need to understand 
which molecular players regulate these processes. The objective of this thesis is to 
investigate whether Tp53INP1 and Tp53INP2 play roles in stress-induced neuronal 
autophagy, as well as determine if Tp53INP2, similarly to its homologue participates in 
mitophagy during mitochondrial stress or injury.     
 
1.9 Hypothesis  
Tp53INP1 and Tp53INP2 are important regulator or neuronal autophagy, acting to 
promote autophagy in response to stress induction.   
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Chapter 2  
2 Materials and Methods 
2.1 Animals 
All animal procedures were carried out according to the protocols approved by the Animal 
Care Committee at University of Western Ontario. Mice carrying targeted mutations for 
TP53INP1 were generated on a C57BL/6 background in the laboratory of Dr. Nelson 
Dusetti (Marseille, France) (Gommeaux et al., 2007). Transgenic mice were maintained on 
a C57BL/6 background and genotyped. Timed-pregnant CD1 mice were obtained from 
Charles River Laboratories (Sherbrooke, QC, CA).  
2.2 Cell Culture 
2.2.1 Primary Cortical Neurons 
Primary cortical neurons were isolated from the cerebral cortices of embryonic day 14.5-
15.5 (E14.5-15.5) fetuses that were dissected from timed pregnant TP53INP1 transgenic 
mice and C57BL/6 mice. Pregnant mice were euthanized via an intra-peritoneal injection 
of 700mg/kg sodium pentobarbital prior to cervical dislocation. Cerebral cortices were 
immediately dissected from individual embryos and following removal of the meninges 
were placed in individual tubes containing 1x Hanks’ Balanced Salt Solution (HBSS) 
[Corning, lot #20-021-CV].  To dissociate the cortical neurons, the individual cortices were 
trypsinized with 1x HBSS solution supplemented with 1.2 mM MgSO4 [Fisher, #M65-3] 
and 1x trypsin [Sigma, #T4549], and placed in a 37oC incubator on a rotor, for 25 minutes.  
Trypsinization was halted with 1x HBSS solution supplemented with 1.2 mM MgSO4, 0.25 
mg/ml DNase I, and 0.2 mg/mL trypsin inhibitor [Roche, #6365752001]. Next, the cell 
suspensions were centrifuged for 4 minutes at 400xg and the supernatant was carefully 
removed. The pellets were resuspended in 1x HBSS solution supplemented with 3 mM 
MgSO4, 1.15 mg/mL trypsin inhibitor and 0.75 mg/mL DNase I. To ensure complete 
dissociation, the cells were triturated 10-14 times through a flame polished glass pipette 
and centrifuged at 400xg for 4 minutes. Following centrifugation, the supernatant was 
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aspirated and the cell pellets were resuspended in 2 mL complete neurobasal media (NBM) 
[Gibco, #21103-049] supplemented with 0.5x B27 [Life Technologies, #17504044], 1xN2 
[Life Technologies, #17502048], 0.5x Glutamax [Life Technologie, #35050061] and 50 
U/mL penicillin: 50µg/mL streptomycin [Life Tehcnologies, #15140-122]. Cell density 
was determined using 0.4% Trypan Blue [SigmaAldrich, #T8154] and a TC20TM 
Automated Cell Counter [BioRad]. Cell suspensions were diluted with supplemented NBM 
to 6 x 105 cells/mL and plated in 35 mm (2mL; 1.2 x 106 cells/dish) Nunc dishes [Thermo 
Scientific] that were previously coated with poly-L-ornithine [Sigma, #P4957]. The 
cultures were maintained at 37oC with 5% CO2. 
2.2.2 Cerebellar Granule Neurons  
Cerebellar granule neurons were isolated from the cerebellum of postnatal day 6 (P6) 
fetuses from timed pregnant TP53INP1 transgenic mice and C57BL/6 mice. Pups were 
euthanized by decapitation and the cerebellum was extracted immediately and dissected 
from individual pups and following the removal of the meninges were placed in individual 
tubes containing 1x Hanks’ Balanced Salt Solution (HBSS) [Corning, lot #20-021-CV] . 
To dissociate the cerebellar neurons, the individual cortices were trypsinized with 1x HBSS 
solution supplemented with 1.2 mM MgSO4 [Fisher, #M65-3] and 1x trypsin [Sigma, 
#T4549], and placed in a 37oC incubator on a rotor, for 25 minutes.  Trypsinization was 
halted with 1x HBSS solution supplemented with 1.2 mM MgSO4, 0.25 mg/ml DNase I, 
and 0.2 mg/mL trypsin inhibitor [Roche, #6365752001]. Next, the cell suspensions were 
centrifuged for 4 minutes at 400xg and the supernatant was carefully removed. The pellets 
were resuspended in 1x HBSS solution supplemented with 3 mM MgSO4, 1.15 mg/mL 
trypsin inhibitor and 0.75 mg/mL DNase I. To ensure complete dissociation, the cells were 
triturated 10-14 times through a flame polished glass pipette and centrifuged at 400xg for 
4 minutes. Following centrifugation, the supernatant was aspirated and the cell pellets were 
resuspended in 2 mL complete neurobasal media (NBM) [Gibco, #21103-049] 
supplemented with 0.5x B27 [Life Technologies, #17504044], 1xN2 [Life Technologies, 
#17502048], 0.5x Glutamax [Life Technologie, #35050061], 20 mM KCl and 50 U/mL 
penicillin: 50µg/mL streptomycin [Life Technologies, #15140-122]. Cell density was 
determined using 0.4% Trypan Blue [SigmaAldrich, #T8154] and a TC20TM Automated 
Cell Counter [BioRad]. Cell suspensions were diluted with supplemented NBM to 6 x 105 
20 
 
cells/mL and plated in 35 mm (2mL; 1.2 x 106 cells/dish) Nunc dishes [Thermo Scientific] 
that were previously coated with poly-L-ornithine [Sigma, #P4957]. The cultures were 
maintained at 37oC with 5% CO2.  
2.2.3 Cell Lines 
HeLa Cervical Cancer Cells. HeLa cells were generously provided by the Schild-Poulter 
Lab, and were maintained in Dulbecco’s Modified Eagle Medium (DMEM) [Gibco, 
#11965118] supplemented with 10% Fetal bovine serum (FBS) [Gibco, #12483-020] and 
0.1% penicillin-streptomycin (100 U/mL) [Sigma #P4333] in T-75 flasks and passaged 
every 2-4 days at a 1:10 dilution.  
2.2.4 Cell Treatments 
Cell transfection. For transient transfection experiments cells were plated in 12-well plates 
on coverslips that were coated with poly-D-lysine [Corning, #354210] (50ug/ml) at a 
density of 65,000 cells/well 24 h prior to transfection with Lipofectamine 2000 [Invitrogen, 
#11668-019] method (Invitrogen).  Cells were transfected with 0.5-1.0ug/ml of plasmid 
DNA per well, using a 1:2.5 DNA: Lipofectamine 2000 ratio.  
Tp53INP2 expression cell experiments were conducted in HeLa cells which were 
transfected with plasmids using Lipofectamine 2000. Cells were transfected with 0.5-
1.0ug/ml of plasmid DNA per well, using a 1:2.5 DNA: Lipofectamine 2000 ratio. 24hrs 
after transfection cells were treated with carbonyl cyanide m-chlorophenyl hydrazone 
(CCCP) [Sigma, #C2759] for 6 hours and 24hours before being fixed with 4% 
paraformaldehyde for 30 mins and stained with Hoechst nuclear stain.  
2.3 Genotyping 
Genotyping was conducted by isolating genomic DNA from tail clips of each pup. Primers 
used to detect the TP53INP1 wild type and knockout alleles were 5’- AAT GTA TGC AAT 
CTT AGC TGA TGC-3’ (forward) and 5’- CCA AAC ACT GTC ACT GTA TTG ATA-
3’ (forward) respectively, with a common reverse primer 5’- TCT TGA GGT AAC ATA 
GTG AAA TGC-3’. The list of PCR reagents can be found in Appendix B Table 3. The 
PCR cycling conditions includes cycling through the following steps for 32 cycles;  94oC 
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for 3 minutes, 94oC for 45 seconds, 62oC for 45 seconds, and 72oC for 1 minute. Following 
this cycling the samples undergo a final step of 72oC for 10 minutes.  
2.4 Protein Extraction and Quantification 
Whole cell extracts were isolated by removing culture media from adhered cells on 35mm 
dishes. Cells were washed twice with 1x PBS and 200uL Lysis buffer [200uL RIPA Lysis 
buffer [Sigma, #R0278], 2uL protease inhibitor cocktail [Sigma, #P8340-5mL], 2uL 
Phosphatase Inhibitor Cocktail 2 [Sigma, #P5726-1mL] were added to each culture dish. 
Cells were scraped into the lysis buffer and transferred to 1.5 mL microcentrifuge tubes 
and placed on ice for 30 minutes. Samples were centrifuged at 12,000xg for 15 minutes at 
4oC. The supernatant from each tube wasa transferred to a fresh 1.5 mL tubes were protein 
concentrations were determined by Pierce BCA Protein Assay Kit [Thermo Scientific, 
#23225].  
2.4.1 Western Blot and Densitometry Analysis 
The volume corresponding to 20 µg of protein was mixed with a volume of 5x Laemmli 
Buffer and β-mercaptoethanol (1:20 dilution) to obtain a 1:5 dilution of the buffer. The 
samples were boiled on a 100oC heating block for 5 mins to reduce disulfide bonds and 
denature proteins. The samples were then cooled on ice for 2-3 minutes prior to being 
loaded onto 1.5mm 15% bis-acrylamide mini-gel (National Diagnostics, #EC-890] and run 
at 30-60 mA for 40-60 minutes. Proteins were then transferred to Immuno-Blot PVDF 
membrane [BioRad, #1620177], previously activated in 100% methanol through semi-dry 
electroblotting.  The membrane was then incubated in blocking solution (5% milk (w/v) in 
1x TBST) for 1 hour at room temperature. The blocking solution was the replaced with 
primary antibody diluted in blocking solution (5% milk (w/v) in 1x TBST) and incubated 
on an orbital shaker overnight at 4oC.  Primary antibodies used included rabbit polyclonal 
LC3B [1:500; Novus Biologicals #NB100-2220], monoclonal mouse anti-β-actin 
[1:10,000; SigmaAldrich #A5441], SQSTM1/p62 [1:1000, Cell Signaling #5114S], 
TP53INP2 [1:1000; Novus Biologicals #NBP2-13466], p53 DINP1 [1:1000; Novus 
Biologicals #NBP1-31694], Cyclophillin-b [1:1000; Abcam #ab16045]. Following 
overnight incubation, the membranes were incubated in secondary antibody diluted in 
blocking solution on an orbital shaker for 1 hr at room temperature. Secondary antibodies 
22 
 
used were horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (H+L) [1:10,000; 
Biorad #1706515] and goat anti-mouse IgG (H+L)[1:10,000, Biorad #1706516]. The 
membrane was then washed with washing buffer [1xTBST; 100mL 10x Tris-buffered 
saline, 900mL ddH2O, 1 mL Tween20] 3 times for 15 mins to remove excess secondary 
antibody. The membrane was then coated with a 1:1 mixture of Clarity Peroxide Reagent 
and Luminol/Enhancer Reagent from Clarity Western ECL Substrate [BioRad, #1705060] 
for 5 mins, before being sandwiched between two transparent overhead projector sheets to 
image. Blots were developed with ChemiDocTM MP Imaging System [BioRad] (Molecular 
Devices).  
Chemiluminescent blots were imaged using Image Lab Software version 5.2 [BioRad]. The 
band analysis tool was used to select the bands of interest and quantify the representative 
protein band for each sample and protein of interest. Relative density was normalized to 
control β-actin or cyclophillin-β level in each lane, and percentage change from the control 
samples were calculated.  
2.5 RNA Extraction and Quantitation   
RNA was extracted from neuronal cultures using Trizol [Invitrogen, # 15596026] reagent, 
according to manufacturer’s protocol. RNA concentration was quantified using NanoDrop 
1000 Spectrophotometer [Thermo Fischer] (Molecular Devices).  
2.5.1 Quantitative RT-PCR  
RNA samples were diluted to 10 ng/µl in UltraPureTM DNAse/RNAse-free distilled H2O 
[Invitrogen, # 10977023]. Primer probes were designed for ribosomal S12 which served as 
a reference gene, and for TP53INP1. Primer sequences  used for probing TP53INP1 were 
5’- TGACTTCATAGATACCTGCCC-3’ (forward) and 5’-
TCACTGGTGTCAGTCAAGCA-3’ (reverse) [SigmaAldrich], and for S12  5’- 
GGAAGGCATAGCTGCTGG-3’ (forward) and 5’- 
CCTCGATGACATCCGACATCCTTGG-3’  [SigmaAldrich]. QuantiFast SYBER Green 
PCR kit [Qiagen, #204154] was used, in which 40ng of RNA was mixed with 21 µL of 
MasterMix. Reagents and cycling conditions can be found on Appendix B. Samples were 
run in CFX ConnectTM Real-Time PCR Detection System [BioRad] (Molecular Devices).  
Cycle threshold (Ct) and melt curves were analyzed using CFX ManagerTM Software 
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[Biorad].  The change in mRNA transcript level was measured by comparing the fold 
change in treated samples relative to untreated controls.  Fold change was measured by 
calculating ∆Ct (treated sample- untreated control) and ∆∆Ct (∆Ct Target Gene - ∆Ct 
Housekeeping Gene), and finally 2-(∆∆Ct) .  
2.6 Hypoxia Conditions  
Primary cortical neurons extracted from embryonic day 14.5-15.5 mice, were subjected to 
hypoxic conditions after five days in vitro. These neurons were treated with 25 µM 
chloroquine, and then transferred to a humidified hypoxia glove box chamber that 
continuously exposed them to 0.5% O2 and 5% CO2 and maintained a 37oC environment 
for respective periods of time. Control cultures were kept at normoxic conditions of 20% 
O2 and 5% CO2 at 37oC.   
2.7 Oxygen-glucose Deprivation Conditions  
Primary cortical neurons extracted from embryonic day 14.5-15.5 mice, were subjected to 
hypoxic conditions after five days in vitro. Primary neurons were stripped of their 
conditioned media (which was collected and maintained for later) and incubated in oxygen-
glucose deprived (OGD) media (in mmol/L: 116 NaCl, 5.3 KCl, 0.8 MgSO4, 1.0 
Na•H2PO4, 1.8 CaCl•2H2O, 20 NaHCO3, 0.02 Phenol Red) containing 25 µM chloroquine, 
and then transferred to a humidified hypoxia glove box chamber that with 0.5% O2 and 5% 
CO2 and maintained a 37oC environment for 2 hours. After the 2 hours incubation,  primary 
neurons underwent reperfusion when the OGD media was removed and replaced with the 
conditioned media that was collected prior to OGD, which contained 25 µM chloroquine. 
The neurons were then incubated at normoxic conditions (20% O2 and 5% CO2) for the 
respective time periods.  
2.8 Immunofluorescence Staining 
Neurons were fixed in 4% PFA (containing 0.2% picric acid in 0.1M phosphate buffer, pH 
7.1) for 30 mins before being washed with 1x phosphate buffered saline (PBS) and stained 
with Hoechst 33342 (0.25 µg/ml) dye. Neurons were then washed 3 times with ice-cold 1x 
PBS while gently rotating on an orbital rotator for 5 mins per wash. Neurons were then 
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incubated in 100% ice-cold methanol (-20oC) for 5 mins at RT in order to permeabilize the 
cells. They were then washed 3x with ice-cold 1xPBS for 5 minutes per wash while gently 
rotating. They were then incubated in blocking solution (2% BSA in 1xTBST) for 1 hour 
at RT. LC3 antibody (Cell Signalling; #2775S) was diluted in 2% BSA (1:100) that also 
contained MAP2 (Abcam, #11267) placed on coverslips. Dishes were incubated overnight 
at 4oC. The following day, neurons were washed 3x with RT 1x PBS for 5 minutes per 
wash with gentle rotation. They were then incubated in secondary antibody Goat-anti-
rabbit Alexa 488 [at a 1:200, Invitrogen #A-11034] and Goat-anti-mouse 568 Phalloidin [a 
1:200, Invitrogen #A12380] in 2% BSA in the dark at RT for 2 hrs. After incubation cells 
were washed 2 times in RT 1x PBS and once in UltraPureTM DNAse/RNAse-free distilled 
H2O for 5 minutes while gently rotating. They were then air dried before mounting on a 
slide using 10 µl ShandonTM Immu-MountTM. [ThermoScientific, #9990412].  
2.8.1 Imaging and Analysis  
Slides were imaged using the Leica SP8 confocal microscope. Slides were imaged at 40x 
objective and 1x zoom. All slides were imaged on the same day, a few hours after the 
coverslips were mounted. Laser power and percentage gain were kept consistent between 
all of the slides, regardless of any variations in staining. Processing involved adjusting the 
exposure of each RGB setting to eliminate background staining, and these optimal values 
were applied to every image to maintain consistency and remove any bias. Image were then 
quantified using ImageJ’s RGB measure, in which the mean RGB of the entire field was 
measured. Because no dead cells contained LC3 punctae, the value for the green measure 
was divided by the total number of live cells to obtain the mean fluorescence per cell. A 
minimum of ten fields per slide were quantified per sample.  
2.9 Statistical Analysis  
All statistical analyses were computed using GraphPad Prism5 (GraphPad Software). Data 
was reported as the mean and standard error of the mean (SEM). Differences between 
groups were demonstrated using ANOVA with post-hoc Tukey’s test and t-test. Statistical 
significance was quantified as p-value <0.05  
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Chapter 3  
3 Results  
3.1 Trophic deprivation of cerebellar granule neurons 
results in autophagy induction  
Tp53INP1 has been implicated in playing a role in the regulation of nutrient deprivation-
induced autophagy in non-neuronal cells, however its role in neuronal autophagy has yet 
to be investigated. The importance of adequately functioning autophagy in neuronal 
homeostasis has been effectively demonstrated, therefore in order to understand if 
Tp53INP1 plays a role in regulating this process, we elicited the use of two potent 
autophagy inducing paradigms; trophic factor deprivation and hypoxia.  
 
Previous studies have demonstrated that the survival of cerebellar granule neurons (CGNs) 
in vitro is dependent on chronic depolarization. For this reason, CGNs are routinely 
cultured in depolarizing K+ concentrations of 25 mM (K25). These high K+ concentrations 
results in chronic depolarization that causes the release of glutamate, an excitatory 
neurotransmitter. This glutamatergic stimulation is said to mimic in vivo interactions with 
the cerebellar mossy fibers, particularly during development. Additionally, it was 
demonstrated that elevated K+ in the culture medium promoted the maturation and survival 
of CGNs in culture (Balázs, Gallo and Kingsbury, 1988). Therefore when CGNs are 
switched to low potassium medium, (5 mM (K5)), they undergo potassium deprivation, 
which results in autophagy induction and cell death (Maycotte, Guemez-gamboa, & 
Moran, 2010). This  model of trophic factor deprivation-induced neuronal apoptosis is 
believed to mimic aspects of de-innervation common in neuronal injury and 
neurodegeneration (Ambacher et al., 2012). Additionally, it was demonstrated that CGNs 
undergoing apoptosis showed increased levels of cathepsin L, a lysosomal endopeptidase 
as well as an increase in autophagosome structures (Kaasik, Rikk, Piirsoo, Zharkovsky, & 
Zharkovsky, 2005).  Inhibition of autophagy with 3-methyladenine (3-MA) resulted in 
partial protection from potassium deprivation-induced apoptosis.  Therefore, we used 
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trophic factor deprivation in CGNs to determine if Tp53INP1 plays a role in neuronal 
autophagy. 
 
3.1.1 Assessing the effect of trophic deprivation on CGNs using 
varying lysosomal inhibitor concentrations  
Since autophagy is a dynamic process, many autophagic studies elicit the use of lysosomal 
inhibitors to inhibit autophagosome turnover and capture autophagic flux, from cargo 
sequestration to lysosomal delivery. Unlike Bafilomycin A1 (Baf A1) which serves to 
inhibit the vacuolar H+ ATPase of the lysosome to prevent its acidification, chloroquine 
(CQ) is a lysomotrophic weak base that enters the lysosome and becomes protonated, 
therefore changing the lysosomal pH (Redmann et al., 2017). We began by determining 
the kinetics of K5 induced autophagy in the presence of the lysosomal inhibitors Baf A1 
or CQ on CGNs extractes from CD1 mice. We carried out trophic factor deprivation by 
replacing the conditioned media that the cells were cultured in (25 mM KCl) for 7 days 
with K5 media (5 mM) containing lysosomal inhibitors. In using these inhibitors, we 
expected that increased levels of autophagy over time would result in increased 
accumulation of LC3-II.  As shown in Figure 3.1A, we found that lower concentrations of 
Baf A1 (25 nM) did not result in increases in LC3-II levels as expected, and that higher 
concentrations (50 nM) were toxic to the cells resulting in cell death, particularly at longer 
duration. However, exposure to K5 media in the presence of CQ at both 5uM and 8uM 
resulted in an increase in LC3-II with increased duration in K5 media. Therefore, in 
proceeding with our paradigm, we used 5 µM CQ. In addition to this, we did not see marked 
increases in basal levels of autophagy when cells were incubated at K25 conditions with 
CQ. This ensured that any increases that were observed during K5 conditions, were not 
solely due to the application of a lysosomal inhibitor but moreover a result of trophic 
deprivation. Furthermore, by evaluating nuclear morphology using Hoechst staining, we 
observed over 50% of a decrease in percentage survival in cells that had undergone 12 
hours of K5 treatment (Figure 3.2B).  Therefore, in further studies we restricted our 
analysis of autophagic flux to 6 hours which preceded the onset of apoptotic cell death 













Figure 3.1. The effect of lysosomal inhibitors bafilomycin A1 and chloroquine on 
LC3-II levels in cerebellar granule neurons subjected to K5 treatment.  To determine 
the kinetics of the effect of K5 treatment on autophagy, cerebellar granule neurons were 
treated with high and low doses of bafilomycin A1 (A) and chloroquine (B) for up to 12 
hours. Western blot analysis was used to determine the effect of both lysosomal inhibitors 











































Figure 3.2. Percent survival of cerebellar granule neurons undergoing 12 hours of trophic 
deprivation. CGNs were subjected to 12 hours of K5 treatment. A. Cells were stained with 
Hoechst nuclear stain and examined for apoptotic morphology.  B. Quantitation of percent 
survival was measured by dividing the number of live cells in each field by the total number of 
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Figure 3.3. Cerebellar granule neurons subjected to trophic deprivation (K5) display 
increased levels of autophagy as measured by LC3-II/LC3-I ratio. Cerebellar granular 
neurons (CGNs) extracted from P7 mice were cultured for 5 days and either maintained in 
cultured media containing 25 mM potassium (K25) or switched to media containing 5 mM 
potassium (K5) and 5 µM CQ. A. Representative western blot depicting changes in LC3 
levels in CGNs incubated in K5 media for up to 6 hours. B. Graphical representation 
demonstrating increased conversion of LC3-I to LC3-II with greater time in K5 media as 
well as increased LC3-II levels. Data is shown as mean ± SEM of 4 independent 




3.2 Tp53INP1-deficient cerebellar granule neurons 
experience significantly attenuated autophagy induction in 
response to trophic deprivation  
Since we saw robust increases in autophagy during trophic deprivation of cerebellar 
granule neurons from CD1 mice, we used trophic deprivation to determine if Tp53INP1 
plays a role in neuronal autophagy.  When we subjected wild-type and Tp53INP1-defiicent 
CGNs to potassium deprivation, we observed the level of autophagy increase with 
increased duration of the trophic deprivation, from 2 to 6 hours, showing significant 
increases from control at 4 and 6 hours (**p<0.01 and ****p<0.0001, respectively). This 
was measured by western blot analysis of changes in the conversion of cytosolic LC3 
(LC3-I) to autophagosome membrane-bound LC3 (LC3-II). However, Tp53INP1-deficient 
neurons demonstrated significantly reduced autophagy at 6 hours compared to that of the 
wild type controls (Figure 3.4). 
In its inactivated form LC3-I appears diffusely dispersed throughout the cytosol. However, 
upon autophagic induction LC3 becomes conjugated with the autophagosomal membrane, 
and therefore accumulates in regions called puncta when visualized using 
immunofluorescence. The formation of punctae structures are indicative of autophagosome 
formation and therefore autophagy induction. It is therefore used as a reliable tool to 
visualize autophagy.   We used immunofluorescence to measure LC3-II protein content 
and distribution in the cells, in order to determine whether differences in LC3 puncta exist 
between CGNs extracted from Tp53INP1+/+ and Tp53INP1-/- mice. After K5 treatment, 
CGNs were fixed and probed for LC3. Images were taken using the Leica SP8, using 
identical % Gains and laser power, and analyzed using ImageJ.  As depicted in Figure 3.5, 
Tp53INP1-/- neurons display fewer, less pronounced LC3 puncta (green) per cell than 
Tp53INP1+/+ following exposure to K5 media in comparison to CGNs from Tp53INP1+/+ 












































































Figure 3.4. Tp53INP1-deficient cerebellar granule neurons show reduced induction in 
trophic deprivation induced autophagy. Cerebellar granule neurons extracted from (P7) 
Tp53INP1+/+ and Tp53INP1-/- mouse pups underwent a media switch from media 
containing 25 mM potassium (K25) to media containing 5 mM potassium (K5) with 5 µM 
CQ for up to 6 hours. A. Representative western blot of LC3-I and LC3-II protein extracted 
from Tp53INP1+/+ and Tp53INP1-/- CGNs. B. Graphical representation of the western blot 
depicting LC3-I and LC3-II  protein ratios normalized to actin . The graph depicts 
increasing levels of  autophagy induction in the wildtype CGNs with increasing time of K5 
exposure, . Additionally, at 6 hours K5 there is a significant reduction in the level of 
autophagy in the Tp53INP1 deficient neurons in comparison to the wildtypes. Data is 






















































3.3 Hypoxic stress activates autophagy induction in primary 
cortical neurons  
In order to investigate the role of Tp53INP1 in a second model of neuronal autophagy we 
used a hypoxia paradigm in primary cortical neurons (PCNs), as oxygen-deprivation is one 
of the most established inducers of autophagy (Fang, Tan, & Zhang, 2015). Previous 
studies have demonstrated that hypoxia-induced autophagy in early stages can be 
neuroprotective, however when prolonged can promote cell death. Therefore, in order to 
observe the effect of hypoxic injury on neuronal cells, we began by subjecting PCNs 
extracted from CD1 embryonic day 14 mice to hypoxic conditions for up to 8 hours. These 
non-transgenic CD1 mice were initially used to determine the period of hypoxic exposure 
necessary for neurons to display an autophagic response. Autophagy was analyzed by 
measuring the conversion of LC3-I to LC3-II through western blot analysis. As shown in 
Figure 3.5. Tp53INP1-deficient cerebellar granule neurons display reduced trophic 
deprivation-induced autophagy. Cerebellar granule neurons extracted from P7 
Tp53INP1+/+ and Tp53INP1-/- mice were cultured for 5 days and then maintained  in media 
containing 25 mM potassium (K25) or switched to media containing 5 mM potassium (K5) 
for 4 hours. CGNs were fixed and probed for LC3 by immunofluorescence . A. CGNs 
immunostained  for LC3 (green) and counterstained with Hoechst dye (blue). Tp53INP1+/+ 
neurons (top row) demonstrate more pronounced puncta formation and less diffuse 
cytosolic expression with increased incubation in K5 media. Tp53INP1-/- neurons 
demonstrate dramatically less puncta formation compared to the wild-types. B. Graphical 
representation of mean fluorescence of LC3 expression per cell, demonstrating significant 
decreases in autophagy induction in basal and stressed conditions in Tp53INP1-/- compared 
to wildtypes. Fluorescence was measured using ImageJ RGB Measure by determining the 
average fluorescence for each wavelength per field and normalized for the total number of 
cells in each field. Data is shown as the mean ± SEM from 3 different pups. *p<0.05 and 
****p<0.0001 in two-way ANOVA. Scale is equal to 17 um and 10 um. 
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Figure 3.6, we observed significant increases in autophagy induction as hypoxic exposure 






























Figure 3.6. Hypoxic stress induces significant autophagy induction. Primary cortical 
neurons were subjected to hypoxic conditions of 0.5% O2  for up to 8 hours to determine 
the kinetics of autophagy induction. A. Western blot analysis was used to measure the 
change in cytosolic LC3 (LC3-I) to autophagosomal membrane LC3 (LC3-II) to 
determine the level of autophagy. B. Assessment of the LC3-II/LC3-i ratio, 
demonstrating the level of autophagy taking place. Autophagy induction begins as early 
as 2 hours of oxygen deprivation, and increases steadily for up to 8 hours Data is shown 





3.4 Hypoxia induced autophagy is attenuated in Tp53INP1-
deficient cortical neurons  
To investigate further into determining whether Tp53INP1 plays a role in neuronal 
autophagy we subjected PCNs extracted from Tp53INP1+/+ and Tp53INP1-/- embryonic 
day 14 mice and cultured for 7 days to hypoxic conditions for up to 8 hours. As shown in 
Figure 3.7, PCNs from Tp53INP1+/+ pups show significant increases in LC3-I to LC3-II 
conversion at 2, 4 and 8 hours of hypoxic exposure (*p<0.05, ***p<0.001, ****p<0.0001 
respectively), similar to what was observed in non-transgenic CD1 mice. However, in the 
PCNs from Tp53INP1-/- pups, the increase in LC3-II is significantly less compared to 
wildtype littermates at 4 and 8 hours of hypoxia, suggesting that the loss of Tp53INP1 is 
attenuating the cells autophagic response to hypoxic stress.  
In addition to western blotting we used immunofluorescence to examine the protein content 
and distribution of LC3-II within PCNs from Tp53INP1+/+ and Tp53INP1-/- pups. Due to 
limitations involving the availability of PCNs, we were only able to compare PCNs from 
Tp53INP1 present and deficient pups for 8 hours of hypoxic conditions. For this assay we 
opted for 8 hours of hypoxia, as based on our findings LC3-II protein levels increase during 
increased hypoxic exposure, therefore we expected to see the evident changes in LC3 
staining as well at this time point. Cells were fixed and probed for LC3. Images were taken 
using the Leica SP8, using identical % Gains and laser power, and analyzed using ImageJ. 
As depicted in Figure 3.8, PCNs from Tp53INP1 deficient mice reduced LC3 expression 
in comparison to Tp53INP1 present PCNs, further suggesting that the absence of 



































Figure 3.7. Autophagy induction in response to hypoxic stress is attenuated in   
Tp53INP1-/- PCNs.  PCNs from Tp53INP1+/+ and Tp53INP1-/- embryonic day 14 pups 
were subjected to hypoxic conditions of 0.5% O2 and 5% CO2 for either 2, 4 or 8 hours 
and protein levels of LC3-II/I were determined by western blot analysis. A. 
Representative western blot demonstrating changes in autophagy as measured by the 
conversion of cytosolic LC3-I to autophagosomal LC3-II that occurs  from 2 hour to 8 
hours in the wildtype PCNs is not observed in the Tp53INP1- deficient PCNs, thereby 
suggesting a reduction in autophagy in the absence of Tp53INP1. B. Graphical 
representation of LC3-I/LC3-II ratio was quantified using ImageLab. Data is shown as 
















































3.5 Oxygen-glucose deprivation and reperfusion results in 
increased autophagy induction 
Recently evidence of autophagic induction during ischemic/hypoxic conditions has 
provoked the question of whether autophagy plays important roles during cerebral 
ischemia. Hypoxia appears to regulate autophagy pathways differently depending on the 
severity and duration of the insult. Regardless of this, oxygen deprivation is one of the most 
established stimuli for autophagy induction and serves as a physiologically relevant model 
in both laboratory and clinical settings. We modelled ischemic injury and reperfusion by 
incubating PCNs from CD1 E14 mice in oxygen-glucose deprived (OGD) media and 
hypoxic conditions for 2 hours, prior to replacing the media with the previously 
conditioned media and placing the cells in normoxic conditions, respectively. We 
monitored the level of autophagy for up to 24 hours reperfusion (RP) and found that 
autophagy was stimulated immediately following OGD at 0 hours and increased 
significantly at 4 and 8 hours as measured by both the conversion of LC3-I to LC3-II 
(Figure 3.9). Therefore, OGD for up to 8 hours results in increases in autophagic induction.  
Figure 3.8. Immunofluorescence staining of LC3 in Tp53INP1 deficient PCNs 
demonstrate reduced hypoxia-induced LC3 expression. PCNs extracted from Tp53INP1+/+ 
and Tp53INP1-/- mice were subjected to hypoxic conditions of 0.5% O2 and 5% CO2, then 
fixed and probed for LC3 (green) and stained with Hoechst nuclear stain (blue). Tp53INP1+/+ 
neurons demonstrate more pronounced LC3 punctae after 8 hours hypoxic exposure compared 
to Tp53INP1-/- B. Graphical representation of mean fluorescence of LC3 expression per cell, 
demonstrating significant decreases in autophagy induction in basal and stressed conditions in 
Tp53INP1-/- compared to wildtypes. Fluorescence was measured using ImageJ RGB Measure 
by determining the average fluorescence for each wavelength per field and normalized for the 
total number of cells in each field. Data is shown as the mean ± SEM from 2 different pups. 


















































In summary, we demonstrate that neurons deficient in Tp53INP1, experience attenuated 
stress-induced autophagy in response to such physiological stressors such as trophic 
deprivation during neuronal injury, and hypoxic conditions that arise during cerebral 
ischemia. These findings suggest that Tp53INP1 plays an important role in stress-induced 







Figure 3.9. Primary cortical neurons subjected to oxygen-glucose deprivation 
conditions show autophagy induction up to 8 hours. Primary cortical neurons extracted 
from embryonic day 14 mice underwent oxygen-glucose deprivation (OGD) by replacing 
media with glucose-free buffer while being subjected to 2 hours in hypoxic conditions of 
0.5% O2 and 5% CO2. After the 2 hours, the cell underwent reperfusion by replacing 
buffer with previously conditioned media, and incubating in normoxic conditions (20% 
O2 and 5% CO2) for various periods of time. A. We used western blot analysis to observe 
changes in LC3-I and LC3-II levels.  B. Graphical representation of western blots. 
quantitation for three different western blots. Data is shown as the mean ± SEM from 3 




3.6 Tp53INP2 responds to mitophagy induction via 
nucleocytoplasmic shuttling to co-localize with the 
autophagosome 
Previous work has demonstrated that Tp53INP2 participates in mTOR-dependent  
autophagy (Mauvezin, Sancho, Ivanova, Palacin, & Zorzano, 2012; Nowak, et al., 2012). 
This was attributed to its ability to shuttle out of the nucleus and interact with autophagy 
related proteins in response to mTOR inhibition. In addition to this it has been observed 
that mouse embryonic fibroblasts (MEFs) deficient in Tp53INP1, the homolog of 
Tp53INP2, display less effective mitophagy leading to the accumulation of damaged 
mitochondria and increased ROS production (Seillier, et al., 2015). However, it had yet to 
be determined whether Tp53INP2 also participates in mitophagy. Therefore, before 
investigating the role of Tp53INP2 in neuronal autophagy, we began by determining 
whether it plays a role in mitophagy in non-neuronal cells.  
 
Since previous studies were conducted primarily in HeLa cells, we too utilized these cells 
to investigate whether Tp53INP2 responds to mitochondrial stress induction. We began by 
treating HeLa cells with carbonyl cyanide m-chlorophenyl hydrazine (CCCP), an 
established mitophagy inducer. CCCP is an ionophore that functions by uncoupling the 
mitochondrial proton gradient and depolarizing the inner mitochondrial membrane. It was 
previously demonstrated that 6 hours of CCCP treatment resulted in mitochondrial network 
fragmentation, and when prolonged to 24 hours resulted in complete loss of mitochondrial 
marker TOM 20  (Villa, et al., 2017).  
 
Often times, the translocation of Parkin to depolarized mitochondria is used as a reliable 
indicator or mitophagy induction (Wang, Nartiss, Stiepe, McQuibban, & Kim, 2012). This 
is due to Parkin’s role in mitophagy in which it tags damaged mitochondria with ubiquitin 
to signal removal via the autophagosome. Therefore, we initially wanted to use Parkin 
translocation in HeLa cells to confirm mitophagy induction, however it became evident 
that CCCP treatment of Parkin transfected cells resulted in nuclear condensation and cell 
death as early as 6 hours  (Figure 3.10A). Therefore, we instead confirmed CCCP-induced 
mitochondrial depolarization using Mitrotracker CMXRos in the absence of ectopic Parkin 
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expression. MitoTracker CMXRos is a lipophilic cationic fluorescent dye that concentrates 
inside the mitochondrial matrix, via attraction to the negative membrane potential of 
polarized mitochondria. Upon depolarization however, a decrease in membrane potential 
results in less accumulation of the dye, and therefore less fluorescent emission 
(Pendergrass, Wolf & Poot, 2004). In doing this we confirmed that membrane potential is 
sufficiently reduced after 24 hours of 10 µM CCCP application (Figure 3.10B).  
 
Using these parameters we transfected HeLa cells with a plasmid expressing Tp53INP2-
mcherry and subjected these cells to 24 hours of CCCP treatment. As depicted in Figure 
3.11, prior to mitochondrial stress induction Tp53INP2 is localized to the nucleus. 
However, upon treatment with CCCP Tp53INP2 shuttles out of the nucleus, forming 
punctae structures in the cytosol.  Additionally, when Tp53INP2 is co-transfected with the 
key autophagosomal protein LC3, the application of mitochondrial stress not only causes 
Tp53INP2 to translocate out of the nucleus but causes it to co-localize with LC3 punctae 
in the cytosol (Figure 3.12). This result provides indication that Tp53INP2 not only 
responds to CCCP-induced mitochondrial stress by undergoing nucleocytoplasmic 





















Figure 3.10. CCCP treatment of HeLa cells results in mitochondrial depolarization. 
To determine whether  CCCP treatment results in Parkin translocation to the mitochondria, 
we transfected HeLa cells with a Parkin-mCherry expressing plasmid (red). Prior to CCCP-
induced mitochondrial stress, Parkin is distributed diffusely within the cell (left). Upon 24 
hours of CCCP treatment, Parkin transfected cells display nuclear condensation and 
apoptotic morphology (right). B. HeLa cells  treated with CCCP for 6 or 24 hours and 










Figure 3.11. CCCP treatment induces Tp53INP2 nucleocytoplasmic shuttling in 
HeLa cells.  Cells were transfected with Tp52INP2-mcherry then treated with 10 µM 
CCCP for 24 hours (second row) or left untreated (first row). Cells were fixed and stained 
with Hoechst nuclear stain (blue). In unstressed cells TP53INP2 is confined to the nucleus 
as demonstrated in the merged image. Upon CCCP treatment for 24 hours TP53INP2 





Figure 3.12. CCCP treatment induces co-localization of Tp53INP2 and LC3 in HeLa 
cells.  Cells were co-transfected with Tp53INP2-mcherry and LC3-eGFP. The first column 
shows untreated cells expressing Tp53INP-mcherry in its characteristic nuclear 
distribution and LC3-eGFP expressed diffusely within the cell. However, upon 24 hours 
CCCP (10 µM) treatment, Tp53INP2 relocates from the nucleus to the cytosol. 
Additionally, LC3-eGFP forms punctate structures within the cytosol characteristic of 
autophagosomes. In the last row, the merged image demonstrates that upon CCCP 
mitophagy induction, Tp53INP2-mcherry co-localizes with LC3-eGFP, as indicated by the 
yellow fluorescence.  
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3.7 Ectopic expression of Tp53INP2 does not sensitize 
HeLa cells to mitophagy induction. 
Previously a study investigating the role of Tp53INP1 and Tp53INP2 as dual regulators of 
autophagy demonstrated that ectopic expression of either gene in HeLa cells in the presence 
of lysosomal inhibitor Baf A1, resulted in increased LC3-II levels during nutrient 
deprivation in comparison to the controls (Sancho, et al., 2012).  To determine if Tp53INP2 
overexpression sensitizes cells to mitophagy induction we transfected HeLa cells with 
Tp53INP2 and subjected them to 24 hours of 10µM CCCP. Furthermore, we too included 
Baf A1 to prevent autophagosomal turnover and assess autophagic flux.  As shown in 
Figure 3.13, western blot analysis demonstrates that ectopic expression of Tp53INP2 
during CCCP-induced mitochondrial stress, resulted in increased mitophagy as measured 
by changes in LC3-II levels. However, although there is a trend towards Tp53INP2 
expression increasing the level of CCCP-induced LC3-II formation, it did not reach 
statistical significance.  Additionally, these changes are recapitulated with the addition of 
Baf A1, in which Tp53INP2 overexpression does not result in enhanced mitophagy.  
In summary we demonstrated that Tp53INP2 responds to CCCP-induced mitochondrial 
stress induction by shuttling out of the nucleus and colocalizing with autophagosomal 
protein LC3, however ectopic expression of Tp53INP2 does not sensitize the cells to 























































Figure 3.13. Ectopic expression of Tp53INP2 does not sensitizes HeLa cells to CCCP-
induced mitophagy. HeLa cells were transfected with TP53INP2 and subjected to 
mitochondrial stress with treatment of 10µM CCCP for 24 hours. A. Western blot analysis 
of LC3-II levels in HeLa cells transfected with TP53INP2 and treated with 10 µM CCCP 
and 100 nM bafilomycin A1 (Baf A1). B. Graphical representation of mitophagy measured 
with LC3-II levels normalized to Actin. Cells transfected with Tp53INP2 demonstrate 
greater mitophagy in comparison to untransfected (UT) controls. Relative density was 





Autophagy is highly conserved cellular process that function in ensuring the turnover of 
proteins and organelles in a number of different cell types. The process plays a particular 
importance in highly specialized neurons, in which the integrity of the structure and 
function is sensitive to defects in autophagy. Unlike other cell types the unique, post-
mitotic nature of neuronal cells necessitates a need for turnover of cellular contents to 
prevent the accumulation of aberrant proteins and organelles that would normally become 
diluted through cellular division. Previous autophagy-related gene loss of function studies 
have demonstrated the importance of autophagy in the central nervous system and how its 
dysregulation  can contribute to the formation of protein aggregates and neurodegeneration 
(Komatsu, et al., 2006). Neuronal autophagy plays a vital role in maintaining neuronal 
metabolic and nutrient homeostasis, preventing the accumulation of toxic proteins and 
damaged organelles. Defects in autophagy have been notable in various neurodegenerative 
diseases including, Parkinson’s disease, Alzheimer’s disease and Huntington’s disease 
(Nixon & Yang, 2012). Previously studies had investigated the role of Tp53INP1in non-
neuronal autophagy using mammalian cell lines to demonstrate that cells deficient in 
Tp53INP1 demonstrated impaired autophagy and higher sensitivity to stress-induced cell 
death. It has also been observed that mouse embryonic fibroblast cells (MEFs) deficient in 
Tp53INP1 display less effective mitophagy leading to the accumulation of damaged 
mitochondria and increased ROS production. Therefore, the goal of this work was to 
determine whether Tp53INP1 plays an important role in neuronal autophagy. Our results 
have demonstrated that Tp53INP1 plays a role in neuronal autophagy as its absence results 
in attenuated autophagy induction in response to trophic factor deprivation and hypoxic 
stress in both cerebellar granule neurons and primary cortical neuron, respectively. We’ve 
also demonstrated that Tp53INP2 responds to mitochondrial stress induction, however its 
expression does not sensitize cells to mitophagy induction.  
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4.1 Tp53INP1 plays a role in neuronal autophagy  
The main aim of this study was to determine if Tp53INP1 plays a role in neuronal 
autophagy and mitophagy. Previously studies using human bone osteosarcoma cells 
(U2OS) and MEFs demonstrated that Tp53INP1 participated in autophagy (Seillier , et al., 
2012) and mitophagy (Seillier, et al., 2015), respectively. These studies demonstrated that 
Tp53INP1 interacts with autophagy-related proteins upon nutrient deprivation and 
rapamycin by colocalizing with LC3 in the cytosol. This study also demonstrated that once 
localized to the autophagosome, Tp53INP1 is degraded by autophagy, much like other 
autophagosome related proteins (Seillier, et al., 2012). This same group also established 
that MEFs deficient in Tp53INP1 displayed an accumulation of defective mitochondria 
resulting from impaired mitophagy (Seillier, et al., 2015). To determine if Tp53INP1 plays 
an important role to neuronal autophagy, we used two paradigms of established neuronal 
autophagy induction, and compared the effect of the presence and absence of Tp53INP1 
on the induction of autophagy.  
 
4.1.1 Tp53INP1-deficient CGNs display attenuated trophic 
deprivation-induced autophagy 
Cerebellar granule neurons (CGNs) are a widely employed model for the investigation of 
neuronal apoptosis, and the role of autophagy in cell death is becoming more and more 
apparent (Canu, et al., 2005). CGNs cultured in medium containing 25 mM KCl (K25) and 
transferred to media containing 5 mM KCl (K5) undergo trophic factor deprivation-
induced apoptosis, displaying apoptotic features after 24 hours (Maycotte, Guemez-
gamboa, & Moran, 2010). Additionally, previous studies have demonstrated the formation 
of autophagosomes preceding apoptotic induction via potassium deprivation, therefore we 
investigated whether Tp53INP1 plays a role in neuronal autophagy using a trophic factor 
deprivation paradigm in CGNs.  
In order to capture autophagic flux the use of autophagosomal inhibitors such as Baf A1 
and CQ are necessary. For this reason, we began by determining the kinetics of 
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autophagosome formation by comparing the effects of both inhibitors to determine the 
kinetics of trophic deprivation on CGNs extracted from CD1 mice. We observed that K5 
treatment for 12 hours resulted in a significant reduction in cell survival, which occurred 
earlier than described in previous reports (Maycotte, Guemez-gamboa, & Moran, 2010). 
This may be attributed to differences in paradigms in which our study elicited the use the 
lysosomal inhibitor chloroquine, an agent that causes the inhibition of autophagy by 
preventing autophagosome turnover.  Interestingly, previous studies had found that the 
inhibition of autophagy with 3-MA protected CGNs from K5-induced cell death 
(Maycotte, Guemez-gamboa, & Moran, 2010). However, this is likely ascribed to the 
difference in inhibitory action of the above inhibitors; 3-MA prevents the initiation of 
autophagy by inhibiting the class III PI3K Vsp34, which serves to regulate autophagosome 
biogenesis through the production of phosphoinositides (Fougeray and Pallet, 2014). CQ 
however, is a lysomotrophic compound that prevents acidification of the lysosome, thereby 
inhibiting fusion between the autophagosome and the lysosome. This blockage in late stage 
autophagy results in an accumulation of autophagosomes which can induce toxicity and 
death (Button et al., 2017).  
We then subjected CGNs extracted from CD1 mice (P7) to K5 potassium deprivation for 
up to 6 hours and observed significant increases in autophagic flux at 4 and 6 hours. When 
we subjected CGNs extracted from Tp53INP1 transgenic mice to the same conditions, we 
observed a significant reduction in the level of autophagy at 6 hours in the Tp53INP1 – 
deficient neurons compared to the wildtype littermates. Additionally, we conducted 
immunofluorescence (IF) staining of LC3, and observed significantly less LC3 in the 
Tp53INP1-/-  CGNs at 2 and 4 hours of K5 conditions as well as in the control. Interestingly 
this finding suggests that not only is stress-induced autophagy impaired in absence of 
Tp53INP1, but basal autophagy may be as well.  Furthermore, it would be interesting to 
see if this reduction in autophagy protects Tp53INP1-deficient neurons from autophagic 
cell death, as has been observed when inhibiting autophagy with 3-MA (Canu, et al., 2005).  
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4.1.2 Tp53INP1- deficient PCNs display attenuated hypoxia-
induced autophagy  
In order to further investigate the role of Tp53INP1 in neuronal autophagy, we used an 
hypoxia/ischemia paradigm in primary cortical neurons (PCNs), as oxygen-deprivation is 
one of the most established inducers of autophagy (Fang et al., 2015). Several studies have 
demonstrated that autophagy is rapidly activated in neurons exposed to hypoxic-ischemic 
conditions (Carloni, Buonocore, and Balduini, 2008; Zhu, et al., 2004) however whether 
the cell induces autophagy to clear itself of damaged organelles and toxic metabolites in 
efforts to promote survival, or whether it promotes cell death through excessive self-
digestions is still in question. For this reason, there is currently no unified theory on 
whether autophagy plays a neuroprotective role or contributes to neurodegeneration under 
these conditions.  
Autophagic responses to hypoxia are said the be regulated differently depending on the 
severity of the insult, as well as the maturity of the brain (Gabryel, Kost and Kasprowska, 
2012). In chronic and moderate hypoxic conditions autophagy is regulated by hypoxia-
inducible factor 1a (HIF-1a), a transcription factor that allows adaption to a large range of 
oxygen concentrations (Mazure & Pouyssegur, 2010). In acute and severe hypoxic 
conditions however, autophagy is regulated by HIF-1a-independent pathways, such as 
mTOR (Mazure & Pouyssegur, 2010). The differential response of neurons to hypoxic 
environments have been demonstrated by several studies that provide evidence for both 
neuroprotective and cell death pathways of autophagy. For example neonatal mice 
subjected to hypoxic/ischemic (HI) injury demonstrate increased autophagosome 
formation and dramatic hippocampal neuronal death (Koike & Shibata, 2008) whereas 
contradictory studies demonstrate that increasing autophagy via rapamycin in neonatal rats 
subjected to HI demonstrated a reduction in necrotic cell death as well as decreased brain 
injury (Carloni, Buonocore and Balduini, 2008). Therefore, greater understanding of the 
autophagy during HI is necessary to better grasp its potential role in stroke afflicted brains.  
In the present study we used a hypoxic stress paradigm to begin determining whether 
Tp53INP1 functions in neuronal autophagy. We initially used PCNs from non-transgenic 
CD1 mice to determine the effect of hypoxia on neuronal autophagy. We also treated the 
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neurons with the CQ to capture autophagic flux; the complete process of autophagy from 
cargo sequestration to delivery and degradation by the lysosome (Klionsky, et al., 2009). 
In the absence of the agent, the cells exhibit rapid autophagic turnover (Appendix C), which 
necessitates its use in our experiments.  
These CD1 neurons demonstrated increases in autophagic flux with increased exposure to 
hypoxic environments for up to 8 hours as measured by the conversion of LC3-I to LC3-II 
(Figure 3.6).  This is in alignment with several studies indicating increases in autophagy 
induction after hypoxia-ischemic exposure (Bellot, et al., 2009; Mazure and Pouysségur, 
2010; Naves et al., 2013). We had originally found that PCN from CD1 mice demonstrate 
steady increases in autophagy for up to 24 hours of hypoxia, but opted on using shorter 
time frames as 1) we saw robust increases of LC3-II at earlier durations, and 2) we did not 
know the extent of the effect of Tp53INP1 deficiency in neuronal autophagy, and therefore 
opted to avoid the possibility of high levels of apoptosis affecting our cultures.  Using these 
parameters, we subjected PCNs from transgenic Tp53INP1 mice to the same hypoxic 
conditions and found that PCNs from Tp53INP1-/- mice displayed significantly less 
increases in autophagy in response to increased duration of hypoxia, specifically at 4 and 
8 hours of exposure, than we had observed for their wild type littermates. In support of 
this, when we conducted IF and stained for LC3, we observed less LC3 staining after 8 
hours of hypoxic exposure in the Tp53INP1-/- neurons compared to the wild types (Figure 
3.8). This result suggests that Tp53INP1-deficient PCNs, have reduced autophagic 
responses to hypoxic stress.   
Another method of autolysosome detection uses an acidotrophic dye called 
monodansylcadaverine (MDC), which accumulates in the acidic vacuoles such as 
lysosomes and autolysosomes of PCNs (Maycotte, Guemez-gamboa, & Moran, 2010). An 
increase from basal lysosomal staining upon autophagy induction would be indictive of 
increased autolysosome formation (Niemann, Takatsuki & Elsässer, 2000). We would 
expect to see an increase in MDC staining in Tp53INP1-present cells and very little change 
from basal lysosome staining in the Tp53INP1-deficient PCNs.    
In addition to this the level of p62, a protein that binds to LC3 of the inner autophagosomal 
membrane as well as ubiquitin residues of the cargo, can be measured. In the absence of 
lysosomal inhibitors, p62 accumulation should inversely correlate to the level of autophagy 
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(Petibone, Majeed, & Casciano, 2016).  Furthermore, we are currently developing 
Adenoviral vectors expressing Tp53INP1, of which can serve to reintroduce the gene into 
Tp53INP1-deficient PCNs to determine if this rescues the reduced autophagy observed in 
these experiments. Additionally, it would be interesting to investigate into the ongoing 
debate of whether increased autophagy enhances cell survival during hypoxic stress or 
induces cell death. This can be investigated by determining whether this reduction in 
autophagy induction in Tp53INP1-/-  PCNs sensitizes the neurons to hypoxia-induced cell 
death, or whether it confers an increased resistance to apoptosis. This can be explored using 
a caspase assay to measure the number of apoptotic cells by detecting the increase in 
fluorescence with the conversion of the caspase-3 substrate DEVD-AMC into AMC 
(Poreba, Strozyk, Salvesen & Drag, 2013). Moreover, to evaluate whether autophagy and 
apoptosis are taking place at the same time, we can perform IF staining of LC3 in 
combination with TUNEL staining to determine if cells exhibit both markers for autophagy 
and apoptosis, respectively (Maycotte, Guemez-gamboa, & Moran, 2010). 
4.2 Ischemic injury/reperfusion increase autophagic flux in 
PCNs 
Cerebral ischemia (ischemic stroke) arises from the lack of blood supply and therefore 
oxygen and nutrients to a localized area of the brain, resulting from blockage of blood 
vessels via a thrombus or embolus (Kalogeris, Baines , Krenz , & Korthuis, 2012). This 
results in damage that typically occurs within 1-2 minutes, and results in profound 
reductions in ATP levels and extensive cell death, specifically in the region immediately 
affected called the core (Tang, Tian , Yi , & Chen , 2016).  The current therapeutic approach 
is called reperfusion, the restoring of blood flow to the brain through administration of 
anticoagulant drugs, such as alteplase and aspirin (Tang, Tian , Yi , & Chen , 2016). 
Reperfusion however poses dangers as the rapid reintroduction of oxygen often results in 
the formation of oxygen radicals which results in further damage through the signaling of 
proinflammatory responses (de Vries et al., 2013). Previous studies have demonstrated 
increased autophagy induction upon ischemic/reperfusion paradigms and have contributed 
conflicting results upon how autophagic inductions affects ischemic damage. In 2006, 
Khan and colleagues demonstrated that mice pretreated with rapamycin, demonstrated 
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reduced infarct size in an intact heart upon ischemic insult (Khan, et al., 2006). However 
other studies have found that autophagy attenuation reduced cell death in cardiomyocyte 
ischemic/reperfusion injury (Valentim, et al., 2006). Therefore, understanding the role of 
autophagy in cerebral ischemia and injury could contribute to improved therapeutic 
approach.  
We modelled ischemia by subjecting PCNs extracted from CD1 mice to 2 hours incubation 
in an OGD media and hypoxic environment. After the 2 hours of ischemic insult, the 
neurons underwent reperfusion (RP) through incubation in glucose-containing media and 
normoxic conditions for up to 12 hours. Since OGD (ischemia) results in the lack of 
nutrients, there is no surprise that autophagy is rapidly induced, however the question 
remains whether this increase also results in increased neuronal cell death. This initial 
experiment served to identify the appropriate parameters to elicit ischemic insults on PCN 
cultured from Tp53INP1 transgenic mice, however we were unable to pursue this at the 
time due to insufficient number of neurons.  
Lastly, these hypoxia/ischemia paradigms would serve as an excellent model to investigate 
the role of Tp53INP1 in neuronal mitophagy. It was previously demonstrated that 
Tp53INP1 knockout MEFs had increased expression of BNIP3 and NIX, suggesting that 
hypoxia-induced mitophagy was not affected by Tp53INP1 deficiency (Seillier, et al., 
2015). However, our studies in PCNs exposed to hypoxic stress suggests that autophagy 
and possibly mitophagy may be affected. It would be interesting to compare the protein 
levels of BNIP3 and NIX in Tp53INP1 wild-type and knockout cells. If Tp53INP1 does in 
fact play a large role in neuronal mitophagy, as an increase in these mitophagy proteins in 
the absence of Tp53INP1 could also suggest the cells ability to compensate and still 
undergo hypoxia-induced mitophagy.  
4.3 Tp53INP2 responds to mitochondrial stress  
In previous studies, it was demonstrated that Tp53INP2 participates in mTOR-dependent 
mammalian autophagy, and this function is attributed to its ability to shuttle out of the 
nucleus to the cytosol where it could interact with autophagy-related proteins (Mauvezin 
et al., 2012; Nowak et al., 2009b). Many of these studies were primarily conducted in HeLa 
cells, therefore we utilized these cells to investigate if Tp53INP2 responds to mitochondrial 
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stress induction, which had not been demonstrated to our knowledge in either non-neuronal 
nor neuronal cells. We used the ionophore CCCP to dissipate the mitochondrial proton 
gradient, an event that according to previous literature is sufficient to induce mitophagy 
(Sargsyan et al., 2015; Wang, Nartiss, Steipe, McQuibban, & Kim, 2012). We transfected 
HeLa cells with Tp53INP2-mCherry and subjected them to 24 hours of 10 µM CCCP 
treatment. In doing this we observed that CCCP treatment resulted in Tp53INP2 
undergoing nucleocytoplasmic shuttling, forming punctae in the cytosol (Figure 3.11). This 
result demonstrated that Tp53INP2 responds to mitochondrial stress. However, whether or 
not its response was due to mitophagy induction was still unknown. Previously multiple 
studies had demonstrated that the colocalization of Tp53INP2 to LC3 was indicative that 
the protein likely plays a role in an autophagic response, although not confirmation of its 
interaction with the autophagosome (Nowak, et al., 2012; Sancho, et al., 2012). Therefore, 
we cotransfected HeLa cells with both LC3-eGFP and Tp53INP2-mCherry and subjected 
the cells to 24 hours of 10 µM CCCP. In doing this we observed that Tp53INP2-mCherry 
not only shuttled out of the nucleus into the cytosol, but also colocalized with newly formed 
LC3 puncta as indicated by the yellow fluorescence (Figure 3.12). This result gave us the 
first lead indicating that Tp53INP2, like its homolog Tp53INP1 (Seillier, et al., 2015) may 
play a role in mitophagy. To further confirm this finding and determine if Tp53INP2 and 
LC3 also colocalize with the mitochondria, we could immunostain for mitochondrial 
protein TOM20. The colocalization of all three markers provide further support that 
Tp53INP2 does in fact participate in mitophagy. 
 
In order to determine whether Tp53INP2 is necessary for mammalian mitophagy, future 
studies could investigate if the loss of Tp53INP2 attenuates mitophagy. To do this we could 
elicit the use of the CRISPR/Cas9 gene editing tool to generate a TP53INP2- deficient 
HeLa cell line (Sun, Lutz, & Tao, 2016). The level of mitophagy could be measured by 
comparing the number of LC3-positive punctae per cell, with and without CCCP treatment, 
in Tp53INP2 present and deficient HeLa cells. If Tp53INP2 is a necessary player in 
mammalian mitophagy, we expect this number to decrease, indicating attenuated 
mitophagy in response to the same mitochondrial stressor. In addition to this we would 
expect a decrease in the LC3-II/LC3-I ratio through western blot analysis in Tp53INP2-
deficient cells in response to mitophagy inducers. To further support this idea, we could 
59 
 
reintroduce Tp53INP2 into Tp53INP2-deficient HeLa cells and determine if reintroduction 
results in an increase in LC3 punctae, thereby rescuing mitophagy induction.  
4.4 Ectopic expression of Tp53INP2 does not sensitize 
HeLa cells to mitophagy induction 
Although the shuttling of Tp53INP2 in response to mitochondrial depolarization suggested 
that Tp53INP2 may participate in mitophagy, previous studies had demonstrated that the 
overexpression of Tp53INP2 in HeLa enhances autophagic flux during starvation 
compared to a pcDNA control as measured by changes in LC3-II levels (Sancho, et al., 
2012; Mauvezin, et al., 2010). Therefore, we aimed to determine if overexpression of 
Tp53INP2 sensitizes cells to mitophagic induction in response to mitochondrial 
depolarization. We transfected HeLa cells and used the same parameters as our previous 
paradigm, subjecting the cells to 24 hours of 10 µM CCCP treatment. When Tp53INP2-
transfected cells are subjected to CCCP-induced mitochondrial stress, the cells do not 
display levels of mitophagy significantly greater than that of the control. Additionally, in 
the presence of Baf A1, we observed higher levels of LC3-II in both UT and Tp53INP2- 
transfected, however similar to the CCCP alone group, we observed no significant 
differences between the two.   
Although ectopic expression of Tp53INP2 does not sensitize cells to mitophagic induction, 
it does not negate the fact that the protein undergoes nucleocytoplasmic shuttling in 
response to mitochondrial depolarization. Therefore, Tp53INP2 may not enhance 









5 Conclusion  
Autophagy has been found to play vital roles in both basal neuronal homeostasis and under 
stress conditions such as hypoxic/ischemic insult. Previous studies have demonstrated the 
role of nuclear proteins Tp53INP1 and Tp53INP2 in mammalian autophagy. In this study. 
we demonstrated that in the absence of Tp53INP1, neuronal autophagy induced via 
hypoxia and trophic factor deprivation is attenuated. We also demonstrated that Tp53INP2 
responds to mitochondrial stress by shuttling out of the nucleus and colocalizing with 
autophagosomal marker LC3. These results suggest a functional role of Tp53INP1 in 
neuronal autophagy and provides a possible target for autophagy regulation in neuronal 





Ashrafi, G. and Schwarz, T. (2012). The pathways of mitophagy for quality control and 
clearance of mitochondria. Cell Death & Differentiation, 20(1), pp.31-42. 
 
Balázs, R., Gallo, V. and Kingsbury, A. (1988). Effect of depolarization on the maturation 
of cerebellar granule cells in culture. Developmental Brain Research, 40(2), pp.269-276. 
 
Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouyssegur, J. and 
Mazure, N. (2009). Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible 
Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains. Molecular and Cellular 
Biology, 29(10), pp.2570-2581. 
 
Button, R., Roberts, S., Willis, T., Hanemann, C. and Luo, S. (2017). Accumulation of 
autophagosomes confers cytotoxicity. Journal of Biological Chemistry, 292(33), 
pp.13599-13614. 
 
Canu, N., Tufi, R., Serafino, A., Amadoro, G., Ciotti, M. and Calissano, P. (2005). Role of 
the autophagic-lysosomal system on low potassium-induced apoptosis in cultured 
cerebellar granule cells. Journal of Neurochemistry, 92(5), pp.1228-1242. 
 
Carloni, S., Buonocore, G. and Balduini, W. (2008). Protective role of autophagy in 
neonatal hypoxia–ischemia induced brain injury. Neurobiology of Disease, 32(3), pp.329-
339. 
 
de Vries, D., Kortekaas, K., Tsikas, D., Wijermars, L., van Noorden, C., Suchy, M., 
Cobbaert, C., Klautz, R., Schaapherder, A. and Lindeman, J. (2013). Oxidative Damage in 
Clinical Ischemia/Reperfusion Injury: A Reappraisal. Antioxidants & Redox Signaling, 
19(6), pp.535-545. 
 
Filadi, R., Pendin, D. and Pizzo, P. (2018). Mitofusin 2: from functions to disease. Cell 




Fougeray, S. and Pallet, N. (2014). Mechanisms and biological functions of autophagy in 
diseased and ageing kidneys. Nature Reviews Nephrology, 11(1), pp.34-45. 
 
Gabryel, B., Kost, A. and Kasprowska, D. (2012). Neuronal autophagy in cerebral ischemia 
– a potential target for neuroprotective strategies?. Pharmacological Reports, 64(1), pp.1-
15. 
 
Gommeaux, J., Cano, C., Garcia, S., Gironella, M., Pietri, S., Culcasi, M., Pébusque, M., 
Malissen, B., Dusetti, N., Iovanna, J. and Carrier, A. (2007). Colitis and Colitis-Associated 
Cancer Are Exacerbated in Mice Deficient for Tumor Protein 53-Induced Nuclear Protein 
1. Molecular and Cellular Biology, 27(6), pp.2215-2228. 
 
Liu, K., Sun, X., Chen, W. and Sun, Y. (2014). Autophagy: a double-edged sword for 
neuronal survival after cerebral ischemia. Neural Regeneration Research, 9(12), p.1210. 
 
Mazure, N. and Pouysségur, J. (2010). Hypoxia-induced autophagy: cell death or cell 
survival?. Current Opinion in Cell Biology, 22(2), pp.177-180. 
 
Naves, T., Jawhari, S., Jauberteau, M., Ratinaud, M. and Verdier, M. (2013). Autophagy 
takes place in mutated p53 neuroblastoma cells in response to hypoxia mimetic 
CoCl2. Biochemical Pharmacology, 85(8), pp.1153-1161. 
 
Nedelsky, N., Todd, P., & Taylor, J. (2008). Autophagy and the ubiquitin-proteasome 
system: Collaborators in neuroprotection. Biochimica Et Biophysica Acta (BBA) - 
Molecular Basis Of Disease, 1782(12), 691-699. doi: 10.1016/j.bbadis.2008.10.002 
 
Niemann, A., Takatsuki, A., & Elsässer, H. (2000). The Lysosomotropic Agent 
Monodansylcadaverine Also Acts as a Solvent Polarity Probe. Journal Of Histochemistry 




Nixon, R., & Yang, D. (2012). Autophagy and Neuronal Cell Death in Neurological 
Disorders. Cold Spring Harbor Perspectives In Biology, 4(10), a008839-a008839. doi: 
10.1101/cshperspect.a008839 
 
Nowak, J., Archange, C., Tardivel-Lacombe, J., Pontarotti, P., Pébusque, M., & Vaccaro, 
M. et al. (2009). The TP53INP2 Protein Is Required for Autophagy in Mammalian 
Cells. Molecular Biology Of The Cell, 20(3), 870-881. doi: 10.1091/mbc.e08-07-0671 
 
Pendergrass, W., Wolf, N., & Poot, M. (2004). Efficacy of MitoTracker Green? and 
CMXrosamine to measure changes in mitochondrial membrane potentials in living cells 
and tissues. Cytometry, 61A(2), 162-169. doi: 10.1002/cyto.a.20033 
 
Petibone, D., Majeed, W., & Casciano, D. (2016). Autophagy function and its relationship 
to pathology, clinical applications, drug metabolism and toxicity. Journal Of Applied 
Toxicology, 37(1), 23-37. doi: 10.1002/jat.3393 
 
Redmann, M., Benavides, G., Berryhill, T., Wani, W., Ouyang, X., & Johnson, M. et al. 
(2017). Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial 
quality and bioenergetic function in primary neurons. Redox Biology, 11, 73-81. doi: 
10.1016/j.redox.2016.11.004 
 
Redmann, M., Dodson, M., Boyer-Guittaut, M., Darley-Usmar, V., & Zhang, J. (2014). 
Mitophagy mechanisms and role in human diseases. The International Journal Of 
Biochemistry & Cell Biology, 53, 127-133. doi: 10.1016/j.biocel.2014.05.010 
 
Rui, Y., Xu, Z., Patel, B., Chen, Z., Chen, D., & Tito, A. et al. (2015). Huntingtin functions 
as a scaffold for selective macroautophagy. Nature Cell Biology, 17(3), 262-275. doi: 
10.1038/ncb3101 
 
Saadi, H., Seillier, M., & Carrier, A. (2015). The stress protein TP53INP1 plays a tumor 





Sancho, A., Duran, J., García-España, A., Mauvezin, C., Alemu, E., & Lamark, T. et al. 
(2012). DOR/Tp53inp2 and Tp53inp1 Constitute a Metazoan Gene Family Encoding Dual 
Regulators of Autophagy and Transcription. Plos ONE, 7(3), e34034. doi: 
10.1371/journal.pone.0034034 
 
Seillier, M., Peuget, S., Gayet, O., Gauthier, C., N'Guessan, P., & Monte, M. et al. (2012). 
TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the 
LC3-interacting region (LIR) and promotes autophagy-dependent cell death. Cell Death & 
Differentiation, 19(9), 1525-1535. doi: 10.1038/cdd.2012.30 
 
Son, J., Shim, J., Kim, K., Ha, J., & Han, J. (2012). Neuronal autophagy and 
neurodegenerative diseases. Experimental & Molecular Medicine, 44(2), 89. doi: 
10.3858/emm.2012.44.2.031 
 
Song, M., Mihara, K., Chen, Y., Scorrano, L., & Dorn, G. (2015). Mitochondrial Fission 
and Fusion Factors Reciprocally Orchestrate Mitophagic Culling in Mouse Hearts and 
Cultured Fibroblasts. Cell Metabolism, 21(2), 273-286. doi: 10.1016/j.cmet.2014.12.011 
 
Stolz, A., Ernst, A., & Dikic, I. (2014). Cargo recognition and trafficking in selective 
autophagy. Nature Cell Biology, 16(6), 495-501. doi: 10.1038/ncb2979 
 
Sun, L., Lutz, B. M., & Tao, Y.-X. (2016). The CRISPR/Cas9 system for gene editing and 
its potential application in pain research. Translational Perioperative and Pain Medicine , 
1(3), pp.22-33. 
 
Tang, Y., Tian, H., Yi, T., & Chen, H. (2016). The critical roles of mitophagy in cerebral 
ischemia. Protein & Cell, 7(10), 699-713. doi: 10.1007/s13238-016-0307-0 
 
Tanida, I., Ueno, T., & Kominami, E. (2004). LC3 conjugation system in mammalian 





Valentim, L., Laurence, K., Townsend, P., Carroll, C., Soond, S., & Scarabelli, T. et al. 
(2006). Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes 
exposed to ischaemia/reperfusion injury. Journal Of Molecular And Cellular 
Cardiology, 40(6), 846-852. doi: 10.1016/j.yjmcc.2006.03.428 
 
Villa, E., Proïcs, E., Rubio-Patiño, C., Obba, S., Zunino, B., & Bossowski, J. et al. (2017). 
Parkin-Independent Mitophagy Controls Chemotherapeutic Response in Cancer 
Cells. Cell Reports, 20(12), 2846-2859. doi: 10.1016/j.celrep.2017.08.087 
 
Wang, Y., Nartiss, Y., Steipe, B., McQuibban, G., & Kim, P. (2012). ROS-induced 
mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial 
degradation by autophagy. Autophagy, 8(10), 1462-1476. doi: 10.4161/auto.21211 
 
Wen, Y.-D., Sheng, R., Zhang, L.-S., Han, R., Zhang , X., Zhang , X.-D., . . . Qin, Z.-H. 
(2008). Neuronal injury in rat model of permanent focal cerebral ischemia is associated 
with activation of autophagic and lysosomal pathways. Autophagy, 4(6), pp.762-769. 
 
Zhang, X., Yan, H., Yuan, Y., Gao, J., Shen, Z., & Cheng, Y. et al. (2013). Cerebral 
ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial 
clearance. Autophagy, 9(9), 1321-1333. doi: 10.4161/auto.25132 
 
Zhu, C., Wang, X., Xu, F., Bahr, B., Shibata, M., & Uchiyama, Y. et al. (2004). The 
influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia–





Appendix A: TP53INP1 Knock-out genotyping  
 
Figure 6.0.1. TP53INP1 mRNA transcript levels to confirm genotyping. Tp53INP1-/- 
mice were treated with camptothecin (CPT), a naturally occurring alkaloid that inhibits 
DNA and RNA synthesis in mammalian cells. CPT treatment has previously been 
demonstrated to cause increased Tp53INP1 gene expression in primary cortical neurons of 
wild-type and non-transgenic mouse models in comparison to their untreated controls. 
However in TP53INP1-/- primary cortical neurons, CPT only results in barely noticeable 
increase from the untreated control samples. Perhaps more importantly, the transcript levels 
are below 10% of that found in untreated TP53INP+/+ control samples, as indicated by the 














































Figure 6.0.2. Genotyping agarose gel for TP53INP1 mice. The genotyping for 
TP53INP1 mice show wildtype bands at 494 base pairs and knockout bands at 689 base 
pair with both bands displayed for homozygotes. Lane 1 contains a 100 base pairs ladder 












Appendix B:  One-Step PCR Reagents and Cycling 
Conditions  
Table 1: One-Step PCR Reagents and Volumes 
 
Table 2: One-Step PCR Cycling Conditions  
 Temperature (oC) Time (minutes) Duration 
1 50 10:00 x 1 
2 95 5:00 x 1 
3 95 0:10 
x 39 
4 60 0:30 
5 65 0.05 Melt Curve: 65oC to 95oC in 0.5oC 







Component  Volume (µL) Final Concentration 
2x Quanti. SYBR Green Buffer 12.5 1x 
Primer A  2.5 1µM 
Primer B  2.5 1µM 
Quanti. RT Mix 0.25 NA 
Template RNA 4 40ng/reaction 
RNA free Water 3.25 NA 
Total rxn volume 25  
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Table 3: Genotyping PCR Reagents  
Reagent Volume (µL) 
10 mM dNTP's 2 
10x buffer (1x) 2.5 
50 mM MgCl2 1.5 
Q solution  5 
Qiagen Taq   0.75 
Nano water 2.25 
Primer #1 STINP F WT (10 µM) 3 
Primer #2 STINP R WT (10 µM) 3 
Primer #3 STINP R CRE (10 µM) 3 











Appendix C: The effect of chloroquine on autophagic flux.  
 
 
Figure 6.0.3. Autophagic flux is captured with the use of chloroquine. CD1 primary 
cortical neurons in which half were treated with 25 µM chloroquine, a lysosomal inhibitor 
and half were left untreated were subjected to hypoxic conditions of 0.5% O2 and 5% CO2 
for up to 24 hours. Samples were probed for LC3-I and LC3-II, with Actin serving as a 
loading control. As shown, autophagic flux is only captured when the lysosomal inhibitor 
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